Rank,Term name,P-value,Z-score,Combined score,Overlapping genes,Adjusted p-value,Old p-value,Old adjusted p-value,gene count
1,Cytoplasmic Ribosomal Proteins WP477,1.5925520735038492e-36,18.616956583227267,1534.5533876442416,"['RPL30', 'RPL3', 'RPL32', 'RPL34', 'RPLP1', 'RPLP0', 'RPL10A', 'RPL8', 'RPL9', 'RPL6', 'RPL7', 'RPS4X', 'RPS15', 'RPL7A', 'RPS14', 'RPS16', 'RPL18A', 'RPS19', 'RPS18', 'RPL35', 'RPLP2', 'RPL38', 'RPL37', 'RPL39', 'RPS10', 'RPS13', 'RPS12', 'RPS9', 'RPS7', 'RPL21', 'RPS8', 'RPL23', 'RPS5', 'RPS6', 'RPL13A', 'RPSA', 'RPS3A', 'RPL37A', 'RPL24', 'RPL27', 'RPL26', 'RPL29', 'RPL10', 'RPL12', 'RPL11', 'RPL36A', 'RPS15A', 'RPL14', 'RPS3', 'RPL13', 'RPS2', 'RPL15', 'RPS27A', 'RPL18', 'RPL17', 'RPL19', 'RPL41', 'RPL35A', 'RPL23A', 'RPS26', 'RPS25', 'RPS28', 'RPS27', 'RPS29', 'RPL27A', 'FAU', 'RPS21', 'RPS24', 'RPS23']",8.886440570151478e-34,0,0,69
2,Electron Transport Chain (OXPHOS system in mitochondria) WP111,5.833592300991963e-14,5.385365853658537,164.10587502960075,"['NDUFB9', 'COX7B', 'NDUFB8', 'NDUFB7', 'UQCRB', 'NDUFB10', 'NDUFB5', 'COX4I1', 'COX17', 'NDUFB3', 'NDUFB2', 'ATP5MC3', 'COX7A2', 'UQCR11', 'UQCR10', 'COX6A1', 'COX5B', 'COX7A1', 'COX7C', 'UQCRH', 'ATP5MC1', 'ATP5IF1', 'ATP5F1B', 'UCP3', 'UQCRFS1', 'ATP5MF', 'ATP5ME', 'COX8A', 'ATP5PF', 'SURF1', 'NDUFA7', 'ATP5PD', 'NDUFA6', 'NDUFA5', 'NDUFA4', 'NDUFA1', 'NDUFC1', 'COX6C', 'ATP5F1E', 'COX6B1', 'UQCRQ', 'NDUFS6', 'NDUFS5', 'SLC25A5', 'SLC25A4', 'SLC25A6']",1.6275722519767578e-11,0,0,46
3,Mitochondrial CIV Assembly WP4922,8.342221811200727e-07,6.114084005695301,85.57740353464935,"['COX8A', 'COA3', 'COX7B', 'SURF1', 'PET100', 'NDUFA4', 'COX4I1', 'COX17', 'COX7A2', 'COX6A1', 'HIGD1A', 'COX5B', 'COX6C', 'COX7C', 'PET117', 'COX6B1', 'SCO2', 'COX14']",0.00015516532568833353,0,0,18
4,Nonalcoholic fatty liver disease WP4396,2.855252716373604e-06,2.5027188037263604,31.950584704638054,"['NDUFB9', 'NDUFA13', 'COX7B', 'NDUFB8', 'NDUFB7', 'UQCRB', 'NDUFB10', 'NDUFB11', 'NDUFB5', 'COX4I1', 'NDUFB3', 'NDUFB2', 'COX7A2', 'UQCR11', 'UQCR10', 'COX6A1', 'COX5B', 'COX7A1', 'COX7C', 'UQCRH', 'CASP7', 'CASP8', 'LEPR', 'MLX', 'UQCRFS1', 'CYC1', 'COX8A', 'XBP1', 'JUN', 'NDUFA7', 'TGFB1', 'NDUFA6', 'NDUFA5', 'NDUFA4', 'NDUFA1', 'NDUFC1', 'COX6C', 'COX6B1', 'UQCRQ', 'NDUFS6', 'DDIT3', 'NDUFS5', 'CYCS', 'BAX']",0.00039830775393411775,0,0,44
5,Oxidative phosphorylation WP623,4.252430020074503e-06,3.9095624516972833,48.35354647263097,"['NDUFB9', 'ATP5PF', 'NDUFB8', 'NDUFA7', 'NDUFB7', 'NDUFA6', 'ATP5PD', 'ATP6AP1', 'NDUFB10', 'NDUFA5', 'NDUFB5', 'NDUFA4', 'ATP6AP2', 'NDUFB2', 'ATP5MC3', 'NDUFC1', 'ATP5F1E', 'ATP5MC1', 'ATP5F1B', 'NDUFS6', 'NDUFS5', 'ATP5MF', 'ATP5ME']",0.00047457119024031446,0,0,23
6,Allograft Rejection WP2328,2.044461569644272e-05,4.277616279069767,46.18880656502625,"['C1QB', 'C1QA', 'ABCB1', 'TGFB1', 'HLA-B', 'HLA-C', 'HLA-A', 'HLA-F', 'HLA-E', 'VEGFA', 'C3', 'CASP7', 'CASP8', 'C6', 'IL5', 'COL5A1', 'HLA-DRA', 'VIM']",0.0019013492597691728,0,0,18
7,"GPCRs, Class A Rhodopsin-like WP455",3.658971951049317e-05,2.6370339994035192,26.939262265463206,"['GPR27', 'OXTR', 'NPFFR1', 'GPR68', 'GPR22', 'CHRM5', 'HTR2B', 'GPR83', 'ADRA1D', 'MCHR1', 'MC4R', 'HTR7', 'GPER1', 'NTSR1', 'GPR34', 'P2RY14', 'NPY1R', 'OPRK1', 'NMBR', 'GPR3', 'SSTR1', 'ADRA2C', 'HTR5A', 'ADRA2A', 'HCRTR2', 'ADORA2A', 'LPAR6', 'ACKR4', 'OR6A2', 'RGL4', 'OR3A2']",0.0029167233552650266,0,0,31
8,Proximal tubule transport WP4917,0.0008040803788000726,3.236020512047057,23.059271596983837,"['SLC47A2', 'ATP6V1G1', 'SLC22A6', 'ABCC2', 'ABCB1', 'SLC3A1', 'ATP1B1', 'AQP1', 'SLC7A9', 'ATP6V0A4', 'ATP6V1E1', 'ATP6V0C', 'ATP6V1D', 'SLC26A6', 'ATP6V1F']",0.05210557928687401,0,0,15
9,Computational Model of Aerobic Glycolysis WP4629,0.0008404125691431292,8.291339396444812,58.716095270732886,"['LDHA', 'TPI1', 'PKM', 'PGK1', 'ALDOA', 'GAPDH', 'PFKM']",0.05210557928687401,0,0,7
10,Mitochondrial complex I assembly model OXPHOS system WP4324,0.001322050899732538,2.670707018272425,17.702971187568384,"['NDUFB9', 'NDUFA13', 'NDUFB8', 'NDUFA7', 'NDUFB7', 'NDUFA6', 'NDUFB10', 'NDUFA5', 'NDUFB11', 'NDUFB5', 'NDUFB3', 'NDUFB2', 'NDUFA1', 'NDUFC1', 'TMEM186', 'NDUFS6', 'NDUFS5', 'NDUFAF4']",0.05577065242511432,0,0,18
11,Selenium Micronutrient Network WP15,0.001322050899732538,2.670707018272425,17.702971187568384,"['SERPINA3', 'GPX2', 'GPX4', 'DIO1', 'HBB', 'APOA1', 'KMO', 'SELENOK', 'PTGS2', 'SELENOH', 'SELENOM', 'PRDX5', 'RFK', 'SELENOW', 'PNPO', 'SEPHS2', 'LDLR', 'MSRB1']",0.05577065242511432,0,0,18
12,Vitamin D Receptor Pathway WP2877,0.0013740479684005089,2.1393288870362652,14.098164902462997,"['COLEC11', 'CDKN1A', 'ABCB1', 'CDKN1B', 'SEMA3B', 'GXYLT2', 'CYP3A5', 'ADAMTS5', 'DUSP10', 'CCND1', 'ADGRE5', 'CLMN', 'DND1', 'TIMP2', 'TIMP3', 'SOSTDC1', 'LGALS9', 'JUNB', 'TGFB1', 'CDKN2C', 'IGFBP5', 'GADD45A', 'CDKN2A', 'G0S2', 'CEACAM1', 'PNOC', 'ZNF257']",0.05577065242511432,0,0,27
13,Peptide GPCRs WP24,0.001496999514991069,3.557062966031483,23.136177963207356,"['MC4R', 'OXTR', 'C5AR1', 'GNRHR', 'NPY1R', 'TAC4', 'OPRK1', 'SSTR1', 'NMBR', 'NTSR1', 'TSHR', 'HCRTR2']",0.05577065242511432,0,0,12
14,TYROBP causal network in microglia WP3945,0.001496999514991069,3.557062966031483,23.136177963207356,"['APBB1IP', 'C3', 'RBM47', 'CD4', 'IGSF6', 'ADAP2', 'DPYD', 'IL18', 'LHFPL2', 'SAMSN1', 'TMEM106A', 'ZFP36L2']",0.05577065242511432,0,0,12
15,Spinal Cord Injury WP2431,0.0014992110866966215,2.2002792046523827,14.308011369702136,"['C1QB', 'BTG2', 'CDKN1B', 'PTGS2', 'AQP1', 'TNFSF13B', 'LGALS3', 'ZFP36', 'CCND1', 'SLIT3', 'SLIT2', 'ROS1', 'EGR1', 'TGFB1', 'IL1R1', 'GADD45A', 'OMG', 'FOS', 'PDYN', 'GFAP', 'NR4A1', 'APEX1', 'LTB', 'VIM', 'TLR4']",0.05577065242511432,0,0,25
16,Cholesterol Biosynthesis Pathway WP197,0.0017147938697992954,5.41557367363819,34.48887730483934,"['IDI1', 'SQLE', 'HMGCS1', 'CYP51A1', 'MSMO1', 'HMGCR', 'DHCR7', 'FDFT1']",0.056285587020470984,0,0,8
17,Mitochondrial complex III assembly WP4921,0.0017147938697992954,5.41557367363819,34.48887730483934,"['UQCRB', 'UQCC3', 'UQCRQ', 'UQCRFS1', 'UQCR11', 'UQCR10', 'CYC1', 'UQCRH']",0.056285587020470984,0,0,8
18,Glycolysis and Gluconeogenesis WP534,0.002152238278887025,3.347531556118719,20.55801785333519,"['LDHA', 'TPI1', 'PKM', 'GOT1', 'PGAM1', 'PGK1', 'ALDOC', 'ENO2', 'ALDOA', 'PFKM', 'GAPDH', 'GCK']",0.06671938664549777,0,0,12
19,Nuclear Receptors Meta-Pathway WP2882,0.003283843825565943,1.5982824686795118,9.140162915323712,"['CDKN1B', 'SRXN1', 'SLC7A11', 'AHR', 'RGS2', 'CCND1', 'CPT2', 'SLCO2B1', 'SLC39A6', 'SLC39A8', 'SLC39A7', 'JUNB', 'SLC39A3', 'SRGN', 'HSP90AA1', 'GPX2', 'ABCC2', 'SLC2A12', 'SLC39A11', 'AIP', 'APOA1', 'SLC39A13', 'SLC39A12', 'TGFBR2', 'TGFBR3', 'SLC7A5', 'B3GNT5', 'ANGPTL4', 'FKBP5', 'FTL', 'ABCB1', 'ABCB4', 'GSTP1', 'PTGS2', 'SLC5A3', 'CYP3A5', 'SLC5A4', 'CYP3A7', 'DNAJB1', 'CBR3', 'EGR1', 'GSTM2', 'JUN', 'TGFB1', 'GADD45B', 'SLC10A1', 'SLC2A9', 'SLC6A7', 'MAFF', 'SPINK13', 'BAX', 'SPRY1']",0.09644130814030506,0,0,52
20,Control of immune tolerance by vasoactive intestinal peptide WP4484,0.00532136124711853,inf,inf,"['TGFB1', 'IL5', 'VIP']",0.14139617028057808,0,0,3
21,Gastric acid production WP2596,0.00532136124711853,inf,inf,"['CCK', 'VIP', 'MUC6']",0.14139617028057808,0,0,3
22,Development and heterogeneity of the ILC family WP3893,0.005845785737038452,5.682644628099173,29.22035338880278,"['IL5', 'NFIL3', 'IL7', 'IL18', 'AHR', 'TOX']",0.14827038369397527,0,0,6
23,Complement and Coagulation Cascades WP558,0.00911958618511846,2.9617653145695364,13.912391583665856,"['C1QB', 'C3', 'C1QA', 'CPB2', 'C6', 'SERPIND1', 'SERPINF2', 'C5AR1', 'MASP2', 'F5']",0.21332689368734886,0,0,10
24,NRF2 pathway WP2884,0.009175454484756667,1.8156985294117647,8.517847339816079,"['SRXN1', 'GSTP1', 'SLC7A11', 'SLC5A3', 'SLC5A4', 'DNAJB1', 'SLC39A6', 'SLC39A8', 'SLC39A7', 'SLC39A3', 'CBR3', 'EGR1', 'GSTM2', 'HSP90AA1', 'GPX2', 'TGFB1', 'ABCC2', 'SLC2A12', 'SLC39A11', 'SLC39A13', 'SLC39A12', 'TGFBR2', 'SLC2A9', 'SLC6A7', 'MAFF', 'FTL']",0.21332689368734886,0,0,26
25,Galanin receptor pathway WP4970,0.00997847999944937,4.735123966942148,21.816252686739297,"['YAP1', 'CDKN1A', 'CDKN1B', 'PRKCD', 'FOS', 'VEGFA']",0.21332689368734886,0,0,6
26,Drug Induction of Bile Acid Pathway WP2289,0.010322269049387848,9.465730800990917,43.29106237713813,"['ABCB1', 'ABCC2', 'SLC10A1', 'SLC51A']",0.21332689368734886,0,0,4
27,MicroRNA for Targeting Cancer Growth and Vascularization in Glioblastoma WP3593,0.010322269049387848,9.465730800990917,43.29106237713813,"['HEY1', 'VEGFB', 'VEGFC', 'VEGFA']",0.21332689368734886,0,0,4
28,Cytokines and Inflammatory Response WP530,0.010942530447291094,5.9174927715819905,26.718060999489474,"['CD4', 'TGFB1', 'IL5', 'IL7', 'HLA-DRA']",0.2180689996281582,0,0,5
29,Sleep regulation WP3591,0.01161655532871794,3.0456587268751107,13.569396466786957,"['CHRNB2', 'OXTR', 'AHCY', 'STAR', 'ADORA2A', 'IL18', 'CRH', 'FOS', 'HCRTR2']",0.22351854735946936,0,0,9
30,Kynurenine Pathway and links to Cellular Senescence WP5044,0.012951848252297287,3.6834320885581735,16.010099376618506,"['CDKN1A', 'TDO2', 'HAAO', 'AHR', 'KMO', 'TLR4', 'ACMSD']",0.24090437749272955,0,0,7
31,Cori Cycle WP1946,0.015827804973406214,4.058323494687131,16.825756763884897,"['LDHA', 'TPI1', 'PGAM1', 'PGK1', 'ALDOA', 'GAPDH']",0.28490048952131186,0,0,6
32,Composition of Lipid Particles WP3601,0.01850031995686623,14.193974411886092,56.63349308031072,"['APOA1', 'APOE', 'LDLR']",0.29154165131404675,0,0,3
33,Imatinib and Chronic Myeloid Leukemia WP3640,0.018756993845180297,3.314799503927243,13.180267969095695,"['PDGFRB', 'SPRED2', 'ABCB1', 'CDKN1B', 'GADD45A', 'PIM1', 'PIM2']",0.29154165131404675,0,0,7
34,Nanomaterial induced apoptosis WP2507,0.018756993845180297,3.314799503927243,13.180267969095695,"['CASP7', 'ENDOG', 'CASP8', 'HTRA2', 'BAX', 'CYCS', 'FADD']",0.29154165131404675,0,0,7
35,Complement Activation WP545,0.018769501804105238,4.733581164807931,18.81845592160017,"['C1QB', 'C3', 'C1QA', 'C6', 'MASP2']",0.29154165131404675,0,0,5
36,Complement system WP2806,0.018945094718557456,2.2005949914155467,8.728022377743098,"['PRNP', 'FKBP2', 'C5AR1', 'APOA1', 'C4BPA', 'LRP2', 'DCN', 'C3', 'C6', 'RPS19', 'MASP2', 'CD59', 'CALR']",0.29154165131404675,0,0,13
37,Metapathway biotransformation Phase I and II WP702,0.02048121115666958,1.6676013513513515,6.48404652199119,"['HS3ST3A1', 'NNMT', 'GSTP1', 'GLYAT', 'CYP2C18', 'CYP3A5', 'NAA80', 'CYP3A7', 'NDST4', 'GAL3ST2', 'SULT4A1', 'GAL3ST3', 'CHST8', 'CHST9', 'GSTM2', 'GPX2', 'GPX4', 'CYP3A43', 'CYP51A1', 'KCNAB1', 'FMO5', 'CYP39A1', 'CYP26A1', 'NAT8L', 'CHST2', 'CHST3']",0.29154165131404675,0,0,26
38,NAD Biosynthesis II (from tryptophan) WP2485,0.020770586641919,6.309936691439582,24.446066502789524,"['TDO2', 'NMNAT1', 'HAAO', 'KMO']",0.29154165131404675,0,0,4
39,Role of Osx and miRNAs in tooth development WP3971,0.020770586641919,6.309936691439582,24.446066502789524,"['NOTCH1', 'NOTCH4', 'DKK1', 'RUNX2']",0.29154165131404675,0,0,4
40,Aryl Hydrocarbon Receptor Pathway WP2873,0.02089904310494959,2.664485932974762,10.306369890252107,"['SLC7A5', 'HSP90AA1', 'JUN', 'CDKN1B', 'TGFB1', 'AIP', 'BAX', 'AHR', 'JUNB']",0.29154165131404675,0,0,9
41,IL-18 signaling pathway WP4754,0.02231624275815891,1.4596696840716983,5.550307109975961,"['SPON1', 'BTG2', 'CEBPB', 'EPB41', 'CD81', 'RGS16', 'COX17', 'HSPB1', 'PTGS2', 'PLD1', 'RND2', 'ACACB', 'ADAMTS5', 'CASP8', 'TMSB4X', 'TIMP3', 'FADD', 'IER3', 'JUN', 'TICAM2', 'USP5', 'IMP3', 'PRKCD', 'FN1', 'IL18', 'NDUFC1', 'FOS', 'BPGM', 'RUNX2', 'VEGFA', 'ACTA2', 'CCNA2', 'NR4A1', 'ARL4D', 'BMP2', 'RFX5', 'CYCS', 'BAX', 'LTB', 'NFKBIE', 'ITM2C', 'ARF6', 'MYH7']",0.3037186209525042,0,0,43
42,Hypertrophy Model WP516,0.023675490820622567,3.550723140495868,13.29147486786362,"['NR4A3', 'MSTN', 'WDR1', 'IL1R1', 'IL18', 'VEGFA']",0.31454580661684267,0,0,6
43,Cardiac Progenitor Differentiation WP2406,0.027135234248909422,2.5075324296040304,9.044474484806104,"['MESP1', 'LIN28B', 'NOTCH1', 'TGFB1', 'ACTC1', 'TNNT2', 'ROR2', 'THY1', 'DKK1']",0.3521269932765455,0,0,9
44,FGF23 signaling in hypophosphatemic rickets and related disorders WP4790,0.029539284666997657,3.9443067602918904,13.891983375695801,"['CDKN1A', 'GALNT3', 'CCND1', 'ROS1', 'FGFR3']",0.36628712987077094,0,0,5
45,Glycolysis in senescence WP5049,0.029539284666997657,3.9443067602918904,13.891983375695801,"['LDHA', 'PKM', 'PGK1', 'ALDOC', 'GAPDH']",0.36628712987077094,0,0,5
46,Thyroxine (Thyroid Hormone) Production WP1981,0.030490479875872018,inf,inf,"['TG', 'TSHR']",0.36986277762470837,0,0,2
47,Photodynamic therapy-induced NFE2L2 (NRF2) survival signaling WP3612,0.03533798809818204,2.7618506269808463,9.23230528214572,"['MAPK11', 'JUN', 'ABCC2', 'SRXN1', 'GSTP1', 'ABCC6', 'FOS']",0.39241086665108554,0,0,7
48,Statin inhibition of cholesterol production WP430,0.03533798809818204,2.7618506269808463,9.23230528214572,"['SQLE', 'APOA1', 'HMGCR', 'APOE', 'ACSS1', 'LDLR', 'FDFT1']",0.39241086665108554,0,0,7
49,HIF1A and PPARG regulation of glycolysis WP2456,0.03586550931757233,4.732039636663914,15.748129430166797,"['LDHA', 'TPI1', 'GPD1', 'GAPDH']",0.39241086665108554,0,0,4
50,Mammary gland development pathway - Puberty (Stage 2 of 4) WP2814,0.03586550931757233,4.732039636663914,15.748129430166797,"['CCND1', 'EGF', 'FN1', 'VIM']",0.39241086665108554,0,0,4
51,"Metabolic pathway of LDL, HDL and TG, including diseases WP4522",0.03586550931757233,4.732039636663914,15.748129430166797,"['ANXA2', 'APOA1', 'APOE', 'LDLR']",0.39241086665108554,0,0,4
52,Oncostatin M Signaling Pathway WP2374,0.0399256769442031,1.8227355390358293,5.870549293962544,"['EGR1', 'CEBPB', 'CDKN1B', 'PRKCH', 'PRKCD', 'RPS6', 'FOS', 'VEGFA', 'CASP7', 'TIMP3', 'PTK2B', 'IL6ST', 'JUNB', 'HRAS', 'LDLR']",0.4284332256704871,0,0,15
53,Canonical and non-canonical Notch signaling WP3845,0.04640759893347523,2.5491779820014626,7.826720925417425,"['NOTCH1', 'MAML2', 'HEY1', 'NOTCH4', 'PSEN2', 'DLL3', 'DLK2']",0.4708261855432577,0,0,7
54,Striated Muscle Contraction Pathway WP383,0.04640759893347523,2.5491779820014626,7.826720925417425,"['TMOD1', 'ACTA2', 'MYOM1', 'ACTC1', 'TNNT2', 'VIM', 'ACTG1']",0.4708261855432577,0,0,7
55,Zinc homeostasis WP3529,0.04640759893347523,2.5491779820014626,7.826720925417425,"['SLC39A6', 'SLC39A11', 'SLC39A8', 'SLC39A13', 'SLC39A7', 'SLC39A12', 'SLC39A3']",0.4708261855432577,0,0,7
56,Genotoxicity pathway WP4286,0.05513603595639448,1.8113039662611834,5.249071528689199,"['IKBIP', 'PLK3', 'BTG2', 'CDKN1A', 'GADD45A', 'PCDH8', 'TRIAP1', 'ACTA2', 'MEX3B', 'RPS27', 'BLOC1S2', 'TRIM22', 'PHLDA3']",0.5462909970507506,0,0,13
57,Farnesoid X receptor pathway WP2879,0.055803919053571294,3.7853014037985138,10.92404363379889,"['SLC10A1', 'ABCB4', 'SLCO2B1', 'FKBP5']",0.5462909970507506,0,0,4
58,Heart Development WP1591,0.05946353848081248,2.3668871434477055,6.68028322711339,"['BMP2', 'NOTCH1', 'HEY1', 'VEGFB', 'VEGFC', 'VEGFA', 'FGF10']",0.5623839741066672,0,0,7
59,Vitamin B12 metabolism WP1533,0.05946353848081248,2.3668871434477055,6.68028322711339,"['SERPINA3', 'CUBN', 'HBB', 'APOA1', 'LRP2', 'APOE', 'LDLR']",0.5623839741066672,0,0,7
60,Matrix Metalloproteinases WP129,0.06081351456220906,2.95771375464684,8.281430620539025,"['MMP26', 'MMP15', 'TIMP2', 'TIMP3', 'MMP21']",0.5655656854285444,0,0,5
61,Apoptosis-related network due to altered Notch3 in ovarian cancer WP2864,0.06399366617514977,1.7593984962406015,4.8365357366073,"['BEX3', 'CDKN1A', 'CDKN1B', 'HSPA5', 'HSPB1', 'YBX3', 'ETS1', 'CASP7', 'PTK2B', 'APOE', 'VIM', 'CARD14', 'IER3']",0.5853846840284193,0,0,13
62,Genes controlling nephrogenesis WP4823,0.06978282456757921,2.1040345556474587,5.601712937597889,"['PDGFRB', 'EMX2', 'EYA1', 'LAMB2', 'SLIT2', 'ETV4', 'GLI3', 'VEGFA']",0.6280454211082129,0,0,8
63,Photodynamic therapy-induced HIF-1 survival signaling WP3614,0.07783607037595548,1.9367924173468236,4.944922191219951,"['LDHA', 'EDN1', 'ANGPT2', 'PKM', 'ANGPT1', 'PGK1', 'BAX', 'PTGS2', 'VEGFA']",0.6683343777962094,0,0,9
64,Amplification and Expansion of Oncogenic Pathways as Metastatic Traits WP3678,0.0804935538353021,3.1541425818882467,7.947108808094716,"['NOTCH1', 'EPAS1', 'TCF7', 'VEGFA']",0.6683343777962094,0,0,4
65,miR-509-3p alteration of YAP1/ECM axis WP3967,0.0804935538353021,3.1541425818882467,7.947108808094716,"['YAP1', 'COL5A1', 'PBX3', 'FN1']",0.6683343777962094,0,0,4
66,Nanoparticle triggered regulated necrosis WP2513,0.0804935538353021,3.1541425818882467,7.947108808094716,"['CASP8', 'TRADD', 'FADD', 'FTL']",0.6683343777962094,0,0,4
67,Extracellular vesicles in the crosstalk of cardiac cells WP4300,0.08144576646978897,2.6288494194318233,6.592675689154411,"['EGF', 'CD81', 'HSPB1', 'PDLIM5', 'TLR4']",0.6683343777962094,0,0,5
68,GDNF/RET signaling axis WP4830,0.08144576646978897,2.6288494194318233,6.592675689154411,"['SALL1', 'EYA1', 'SPRY1', 'SLIT2', 'GLI3']",0.6683343777962094,0,0,5
69,Oxidation by Cytochrome P450 WP43,0.08460811033396497,1.993121762221932,4.922462943437216,"['CYP39A1', 'CYB5R1', 'CYP26A1', 'CYP3A43', 'CYP51A1', 'CYP3A5', 'CYP2C18', 'CYP3A7']",0.6763040699482512,0,0,8
70,Senescence and Autophagy in Cancer WP615,0.08484101235909962,1.5004500761667359,3.7015746523818134,"['GABARAPL2', 'GABARAPL1', 'JUN', 'CDKN1A', 'CEBPB', 'TGFB1', 'CDKN1B', 'GSN', 'IGFBP5', 'CDKN2A', 'FN1', 'CXCL14', 'GABARAP', 'BMP2', 'MAP1LC3A', 'IGFBP7', 'IL6ST', 'HRAS', 'SLC39A3']",0.6763040699482512,0,0,19
71,Exercise-induced Circadian Regulation WP410,0.0929639518679714,1.671280276816609,3.970198956978609,"['PER2', 'DNAJA1', 'IDI1', 'DAZAP2', 'HSPA8', 'CLDN5', 'CEBPB', 'RBPMS', 'GSTP1', 'UCP3', 'G0S2', 'HERPUD1']",0.7306181005961696,0,0,12
72,Ovarian infertility WP34,0.09879164612722746,2.1841068022886203,5.0556442526459655,"['EGR1', 'CEBPB', 'CDKN1B', 'MSH5', 'BMPR1B', 'PRLR']",0.7625870460002501,0,0,6
73,Differentiation Pathway WP2848,0.101131615419388,1.8933002481389578,4.338180367161061,"['NOTCH1', 'TGFB1', 'EGF', 'FST', 'FGF1', 'DKK1', 'VEGFA', 'FGF10']",0.7625870460002501,0,0,8
74,Nucleotide-binding Oligomerization Domain (NOD) pathway WP1433,0.101131615419388,1.8933002481389578,4.338180367161061,"['NDUFA13', 'CASP7', 'HSP90AA1', 'CASP8', 'ACAP1', 'IL18', 'NLRC4', 'AAMP']",0.7625870460002501,0,0,8
75,Cholesterol Biosynthesis with Skeletal Dysplasias WP4804,0.10726597806398323,3.5475650020635574,7.9197393259865505,"['CYP51A1', 'DHCR24', 'DHCR7']",0.7773300748013331,0,0,3
76,Mammary gland development pathway - Involution (Stage 4 of 4) WP2815,0.10726597806398323,3.5475650020635574,7.9197393259865505,"['CHI3L1', 'BAX', 'IL6ST']",0.7773300748013331,0,0,3
77,Mevalonate pathway WP3963,0.10726597806398323,3.5475650020635574,7.9197393259865505,"['HMGCS1', 'HMGCR', 'ACAT2']",0.7773300748013331,0,0,3
78,Regulation of sister chromatid separation at the metaphase-anaphase transition WP4240,0.1096102980827495,2.703314851952342,5.976553214418898,"['PTTG1', 'BUB3', 'ANAPC11', 'MAD2L1']",0.7827405427684573,0,0,4
79,Monoamine GPCRs WP58,0.11081810551739807,1.9486905138243804,4.286856273151509,"['HTR7', 'CHRM5', 'HTR2B', 'ADRA1D', 'HTR5A', 'ADRA2C', 'ADRA2A']",0.7827405427684573,0,0,7
80,Osteoblast differentiation WP4787,0.11348663120209976,1.4141263756032803,3.077238315558734,"['PRKCH', 'NOTCH1', 'WNT5B', 'NOTCH4', 'PRKCD', 'WNT8A', 'FGF1', 'WNT16', 'RUNX2', 'GLI3', 'GLI2', 'DLL3', 'MAPK11', 'BMP2', 'HEY1', 'PRKD1', 'BMPR1B', 'FGFR4', 'FGFR3', 'FGF10']",0.78279723625771,0,0,20
81,Lung fibrosis WP3624,0.1193202296464681,1.8029855449210288,3.833047012969198,"['EDN1', 'CEBPB', 'TGFB1', 'IL5', 'EGF', 'SFTPC', 'FAM13A', 'FGF1']",0.78279723625771,0,0,8
82,Glucocorticoid Receptor Pathway WP2880,0.1199134857346932,1.5781552057442696,3.347243122026386,"['SRGN', 'TGFBR3', 'RGS2', 'HSP90AA1', 'MGAM', 'JUN', 'GADD45B', 'B3GNT5', 'SPINK13', 'SPRY1', 'ANGPTL4', 'PTGS2']",0.78279723625771,0,0,12
83,Apoptosis Modulation and Signaling WP1772,0.12468588758262703,1.4571337376316629,3.033690664596782,"['JUN', 'ENDOG', 'CRADD', 'IL1R1', 'CDKN2A', 'TRADD', 'HTRA2', 'FOS', 'PTPN13', 'CASP7', 'CASP8', 'CYCS', 'BAX', 'PRKD1', 'FADD', 'BCL2L2']",0.78279723625771,0,0,16
84,Bladder cancer WP2828,0.12539154250866796,1.7039304923458833,3.5378949018509394,"['CDKN1A', 'RPS6KA5', 'CCND1', 'EGF', 'CDKN2A', 'DAPK2', 'HRAS', 'FGFR3', 'VEGFA']",0.78279723625771,0,0,9
85,Metabolic reprogramming in colon cancer WP4290,0.12972690879231075,1.6322219684859558,3.3335256746868787,"['ACLY', 'LDHA', 'PKM', 'PGAM1', 'PGK1', 'PYCR1', 'PYCR2', 'PDHB', 'SLC16A3', 'GAPDH']",0.78279723625771,0,0,10
86,Hematopoietic Stem Cell Differentiation WP2849,0.13187941057536148,1.8402691654035184,3.7281411809467424,"['CIITA', 'NOTCH1', 'IL5', 'PIM1', 'FOSB', 'FOS', 'RUNX1']",0.78279723625771,0,0,7
87,"GPCRs, Class B Secretin-like WP334",0.13213525160626988,2.1505012954827083,4.352462468914978,"['VIPR1', 'CALCR', 'ADGRG2', 'ADGRE5', 'ADGRL4']",0.78279723625771,0,0,5
88,Pregnane X receptor pathway WP2876,0.13213525160626988,2.1505012954827083,4.352462468914978,"['HSP90AA1', 'ABCB1', 'ABCC2', 'CYP3A5', 'CYP3A7']",0.78279723625771,0,0,5
89,Simplified Interaction Map Between LOXL4 and Oxidative Stress Pathway WP3670,0.13213525160626988,2.1505012954827083,4.352462468914978,"['BMP2', 'TGFB1', 'SUV39H1', 'FN1', 'IGFBP7']",0.78279723625771,0,0,5
90,Base Excision Repair WP4752,0.13911392985013565,1.720881269268366,3.3943729830446574,"['POLE4', 'POLD4', 'FEN1', 'NEIL2', 'POLD1', 'APEX1', 'POLE2', 'POLE3']",0.78279723625771,0,0,8
91,Folate Metabolism WP176,0.13911392985013565,1.720881269268366,3.3943729830446574,"['SERPINA3', 'GPX2', 'AHCY', 'GPX4', 'RFK', 'HBB', 'APOA1', 'LDLR']",0.78279723625771,0,0,8
92,BMP2-WNT4-FOXO1 pathway in primary endometrial stromal cell differentiation WP3876,0.14265980773265655,2.365194054500413,4.605724524792885,"['BMP2', 'SST', 'DKK1', 'DCN']",0.78279723625771,0,0,4
93,Dopaminergic Neurogenesis WP2855,0.14265980773265655,2.365194054500413,4.605724524792885,"['TGFB1', 'ASCL1', 'SLC18A2', 'GLI2']",0.78279723625771,0,0,4
94,Genes targeted by miRNAs in adipocytes WP1992,0.14265980773265655,2.365194054500413,4.605724524792885,"['KCNE1', 'TMSB4X', 'KCNQ1', 'ERG']",0.78279723625771,0,0,4
95,Interactions between immune cells and microRNAs in tumor microenvironment WP4559,0.14265980773265655,2.365194054500413,4.605724524792885,"['TGFB1', 'STAT6', 'TLR4', 'TGFBR2']",0.78279723625771,0,0,4
96,Cells and molecules involved in local acute inflammatory response  WP4493,0.14315732418357488,4.728960396039604,9.192205635268547,"['C3', 'C6']",0.78279723625771,0,0,2
97,Codeine and Morphine Metabolism WP1604,0.14315732418357488,4.728960396039604,9.192205635268547,"['ABCB1', 'ABCC2']",0.78279723625771,0,0,2
98,Nucleotide GPCRs WP80,0.14315732418357488,4.728960396039604,9.192205635268547,"['ADORA2A', 'LPAR6']",0.78279723625771,0,0,2
99,Platelet-mediated interactions with vascular and circulating cells WP4462,0.14315732418357488,4.728960396039604,9.192205635268547,"['TGFB1', 'TLR4']",0.78279723625771,0,0,2
100,Robo4 and VEGF Signaling Pathways Crosstalk WP3943,0.14315732418357488,4.728960396039604,9.192205635268547,"['SLIT2', 'VEGFA']",0.78279723625771,0,0,2
101,Unfolded protein response WP4925,0.14595333898740304,1.8925619834710743,3.642175551174107,"['PPP1R15A', 'XBP1', 'CASP8', 'HSPA5', 'DDIT3', 'TXNIP']",0.78279723625771,0,0,6
102,VEGFA-VEGFR2 Signaling Pathway WP3888,0.14636102276689322,1.1590276374576234,2.2272790143367036,"['TRAF3IP2', 'HSPB1', 'RPL10A', 'ETS1', 'RPL7', 'HERPUD1', 'ACTG1', 'TUBB8', 'TUBA1C', 'RPS6KA5', 'RPL18A', 'CCND1', 'TMSB4X', 'RPLP2', 'CHAC1', 'ATP6V1E1', 'EPHB2', 'HRAS', 'CGNL1', 'TMOD1', 'DUSP5', 'HSP90AA1', 'TRPC3', 'PRKCD', 'RPS6', 'GAB1', 'RPL13A', 'DKK1', 'RCN1', 'RAB37', 'RHOJ', 'MMRN2', 'TXNIP', 'RPL27', 'PRKD1', 'RPL26', 'ERG', 'ALDOA', 'GAPDH', 'FJX1', 'ARF6', 'KANK1', 'SET', 'EPB41', 'NOTCH4', 'PTGS2', 'ACACB', 'APOLD1', 'LDHA', 'DNAJB4', 'PGK1', 'DNAJB9', 'PTK2B', 'STAT6', 'IGFBP7', 'MYH11', 'FADD', 'CCT7', 'EGR1', 'JUN', 'SDF2L1', 'EGR3', 'FN1', 'BMX', 'RAB11A', 'VEGFA', 'DNAJA1', 'NR4A1', 'BMP2', 'NR4A3', 'PTPN9', 'CYCS', 'PTPN6', 'CALR']",0.78279723625771,0,0,74
103,Bile acids synthesis and enterohepatic circulation  WP4389,0.1501062800709229,2.8378043747420554,5.38164542416619,"['SLC10A1', 'FGFR4', 'LDLR']",0.78279723625771,0,0,3
104,Blood Clotting Cascade WP272,0.1501062800709229,2.8378043747420554,5.38164542416619,"['F8A1', 'SERPINF2', 'F5']",0.78279723625771,0,0,3
105,Pathogenesis of SARS-CoV-2 Mediated by nsp9-nsp10 Complex WP4884,0.1501062800709229,2.8378043747420554,5.38164542416619,"['CD4', 'HLA-DRA', 'CD247']",0.78279723625771,0,0,3
106,Selective expression of chemokine receptors during T-cell polarization WP4494,0.1501062800709229,2.8378043747420554,5.38164542416619,"['CD4', 'TGFB1', 'IL5']",0.78279723625771,0,0,3
107,Trans-sulfuration pathway WP2333,0.1501062800709229,2.8378043747420554,5.38164542416619,"['AHCY', 'GOT1', 'MAT2B']",0.78279723625771,0,0,3
108,Pre-implantation embryo WP3527,0.1547571059520088,1.7432605905006417,3.2527472329893823,"['EGR1', 'ZFP36', 'DLX2', 'DDIT3', 'FOSB', 'SOX8', 'ZFP36L2']",0.7922427992772562,0,0,7
109,Tryptophan metabolism WP465,0.1547571059520088,1.7432605905006417,3.2527472329893823,"['TDO2', 'HAAO', 'ALDH1A2', 'AOX1', 'DHCR24', 'CYP2C18', 'ACMSD']",0.7922427992772562,0,0,7
110,Nuclear Receptors in Lipid Metabolism and Toxicity WP299,0.16168166963787897,1.97112074900179,3.591630127655741,"['CYP26A1', 'ABCD2', 'ABCB1', 'ABCC2', 'ABCB4']",0.8201670150721496,0,0,5
111,Ferroptosis WP4313,0.16402343014247636,1.5774375948145083,2.8516064938204826,"['PRNP', 'MAP1LC3A', 'GPX4', 'ACSL5', 'SAT2', 'SLC39A8', 'SLC7A11', 'CP', 'FTL']",0.8245502163919082,0,0,9
112,"GPCRs, Other WP117",0.16618338089131343,1.5266502883999145,2.739823391385973,"['HTR7', 'ADGRV1', 'ADORA2A', 'ADGRF5', 'GNRHR', 'ADRA1D', 'GPR83', 'MCHR2', 'NTSR1', 'GPR135']",0.827949344083508,0,0,10
113,Catalytic cycle of mammalian Flavin-containing MonoOxygenases (FMOs) WP688,0.17464520030623307,inf,inf,['FMO5'],0.846627615661858,0,0,1
114,Nicotine Metabolism WP1600,0.17464520030623307,inf,inf,['AOX1'],0.846627615661858,0,0,1
115,Major receptors targeted by epinephrine and norepinephrine WP4589,0.1790359473980273,2.1022112120378016,3.61615786435702,"['ADCY10', 'ADRA1D', 'ADRA2C', 'ADRA2A']",0.846627615661858,0,0,4
116,NOTCH1 regulation of endothelial cell calcification WP3413,0.1790359473980273,2.1022112120378016,3.61615786435702,"['NOTCH1', 'FGFR3', 'VEGFA', 'DLL3']",0.846627615661858,0,0,4
117,Phytochemical activity on NRF2 transcriptional activation WP3,0.1790359473980273,2.1022112120378016,3.61615786435702,"['AIMP2', 'CEBPB', 'SLC7A11', 'EPHB2']",0.846627615661858,0,0,4
118,Tryptophan catabolism leading to NAD+ production WP4210,0.1790359473980273,2.1022112120378016,3.61615786435702,"['NMNAT1', 'TDO2', 'HAAO', 'KMO']",0.846627615661858,0,0,4
119,Adipogenesis WP236,0.18149244263787165,1.2914004914004913,2.203828227574346,"['GDF10', 'CDKN1A', 'CEBPB', 'TGFB1', 'WNT5B', 'GADD45B', 'EPAS1', 'GADD45A', 'ASIP', 'EBF1', 'AHR', 'PRLR', 'SFRP4', 'CYP26A1', 'BMP2', 'DDIT3', 'NDN', 'ID3', 'STAT6', 'IL6ST', 'PCK2']",0.8510317898481713,0,0,21
120,Development of ureteric collection system WP5053,0.18315565062942762,1.5771987868762063,2.677167089464783,"['SALL1', 'CCND1', 'SPRY1', 'SLIT2', 'ETV4', 'GLI3', 'FREM2', 'GLI2']",0.8516737754268385,0,0,8
121,Photodynamic therapy-induced AP-1 survival signaling. WP3611,0.18607347402813745,1.4788131208609272,2.486792347011991,"['CCNA2', 'MAPK11', 'CDKN1A', 'HSP90AA1', 'JUN', 'CCND1', 'CDKN2A', 'BAX', 'FOS', 'JUNB']",0.8580908967578571,0,0,10
122,EDA signaling in hair follicle development WP3930,0.1972574719356691,2.364630623194387,3.8383758750554677,"['SOSTDC1', 'LTB', 'DKK1']",0.8947366880939457,0,0,3
123,Osteoclast Signaling WP12,0.1972574719356691,2.364630623194387,3.8383758750554677,"['AIMP2', 'ATP6V1G1', 'GPR68']",0.8947366880939457,0,0,3
124,DNA Mismatch Repair WP531,0.20133174735262682,1.6696159455517745,2.67606251976532,"['POLE4', 'POLD4', 'POLD1', 'RPA3', 'POLE2', 'POLE3']",0.8947366880939457,0,0,6
125,Oxidative Damage WP3941,0.20717145815183197,1.5139784946236559,2.383317857926175,"['C1QB', 'C1QA', 'CDKN1A', 'CDKN1B', 'GADD45A', 'C5AR1', 'CYCS', 'NFKBIE']",0.8947366880939457,0,0,8
126,ACE Inhibitor Pathway WP554,0.21175598013626779,3.1523652365236523,4.893481824345137,"['TGFB1', 'ATP6AP2']",0.8947366880939457,0,0,2
127,Arachidonate Epoxygenase / Epoxide Hydrolase WP678,0.21175598013626779,3.1523652365236523,4.893481824345137,"['COX8A', 'GSTP1']",0.8947366880939457,0,0,2
128,LncRNA-mediated mechanisms of therapeutic resistance WP3672,0.21175598013626779,3.1523652365236523,4.893481824345137,"['CDKN1A', 'ABCB1']",0.8947366880939457,0,0,2
129,Metabolism of alpha-linolenic acid WP4586,0.21175598013626779,3.1523652365236523,4.893481824345137,"['ALOX12', 'PTGS2']",0.8947366880939457,0,0,2
130,miR-517 relationship with ARCN1 and USP1 WP3596,0.21175598013626779,3.1523652365236523,4.893481824345137,"['CDKN1A', 'ARCN1']",0.8947366880939457,0,0,2
131,Somitogenesis in the context of spondylocostal dysostosis WP4785,0.21175598013626779,3.1523652365236523,4.893481824345137,"['NOTCH1', 'DLL3']",0.8947366880939457,0,0,2
132,Differentiation of white and brown adipocyte WP2895,0.21807202433830936,1.8918249380677126,2.881116733263711,"['CEBPB', 'BMP2', 'ZIC1', 'PRDM16']",0.8947366880939457,0,0,4
133,ERK Pathway in Huntington's Disease WP3853,0.21807202433830936,1.8918249380677126,2.881116733263711,"['CASP7', 'RPS6KA5', 'EGF', 'HRAS']",0.8947366880939457,0,0,4
134,Mammalian disorder of sexual development WP4842,0.21807202433830936,1.8918249380677126,2.881116733263711,"['MAPK11', 'EMX2', 'FST', 'SOX8']",0.8947366880939457,0,0,4
135,TGF-B Signaling in Thyroid Cells for Epithelial-Mesenchymal Transition WP3859,0.21807202433830936,1.8918249380677126,2.881116733263711,"['TGFB1', 'FN1', 'VIM', 'RUNX2']",0.8947366880939457,0,0,4
136,TP53 network WP1742,0.21807202433830936,1.8918249380677126,2.881116733263711,"['CDKN1A', 'CDKN2A', 'GADD45A', 'BAX']",0.8947366880939457,0,0,4
137,DNA damage response WP707,0.22342877293097227,1.3519943188543022,2.0261833279308314,"['CDKN1A', 'CDKN1B', 'CASP8', 'CCND1', 'CCNE2', 'GADD45B', 'GADD45A', 'CHEK2', 'CYCS', 'BAX', 'GADD45G', 'RAD9A']",0.9002962249277264,0,0,12
138,Hereditary leiomyomatosis and renal cell carcinoma pathway WP4206,0.2274290101054764,1.689237033103204,2.501620063647714,"['LDHA', 'RPS6', 'PDHB', 'ACACB', 'VEGFA']",0.9002962249277264,0,0,5
139,Host-pathogen interaction of human coronaviruses - apoptosis WP4864,0.2274290101054764,1.689237033103204,2.501620063647714,"['MAPK11', 'CASP7', 'CASP8', 'BAX', 'FADD']",0.9002962249277264,0,0,5
140,Kallmann's Syndrome WP5074,0.2274290101054764,1.689237033103204,2.501620063647714,"['PLXND1', 'TMEM98', 'CHD7', 'GNRH1', 'ASCL1']",0.9002962249277264,0,0,5
141,Cytosolic DNA-sensing pathway WP4655,0.2287911178688781,1.3915806388780678,2.0525060753580338,"['MAVS', 'CASP8', 'TRADD', 'POLR1C', 'IL18', 'POLR2E', 'FADD', 'TMEM173', 'POLR2K', 'POLR2L']",0.9002962249277264,0,0,10
142,TGF-beta Receptor Signaling WP560,0.23089351240253259,1.4193214729002896,2.080439513110799,"['TGFBR3', 'JUN', 'TGFB1', 'EGF', 'FST', 'FOS', 'HRAS', 'RUNX2', 'TGFBR2']",0.9002962249277264,0,0,9
143,Photodynamic therapy-induced unfolded protein response WP3613,0.2315029625145353,1.5767217630853994,2.3070003277527023,"['PPP1R15A', 'XBP1', 'HSPA5', 'DDIT3', 'DNAJB9', 'CALR']",0.9002962249277264,0,0,6
144,Host-pathogen interaction of human coronaviruses - MAPK signaling WP4877,0.23233450965876812,1.455621301775148,2.124591509331221,"['IFITM3', 'MAPK11', 'JUN', 'IFITM2', 'IFI27', 'DDIT3', 'FOS', 'JUNB']",0.9002962249277264,0,0,8
145,Mevalonate arm of cholesterol biosynthesis pathway WP4190,0.24729915408791658,2.02664937208891,2.8315463942052013,"['IDI1', 'HMGCS1', 'HMGCR']",0.9451570409661469,0,0,3
146,Neuroinflammation WP4919,0.24729915408791658,2.02664937208891,2.8315463942052013,"['JUN', 'FOS', 'TLR4']",0.9451570409661469,0,0,3
147,Prader-Willi and Angelman Syndrome WP3998,0.25143505645826375,1.3517029328287606,1.8661212581762396,"['GABRR2', 'MAGEL2', 'CDKN2C', 'CCND1', 'DLX5', 'CDKN2A', 'NDN', 'GNRH1', 'TYR', 'GABRD']",0.9544269490048379,0,0,10
148,Myometrial relaxation and contraction pathways WP289,0.2589038133907867,1.1833610995418575,1.5990742718105053,"['RYR1', 'OXTR', 'RGS16', 'ACTG1', 'RGS4', 'RGS5', 'RGS2', 'GNG4', 'PLCG2', 'IGFBP6', 'YWHAG', 'CORIN', 'JUN', 'PRKCH', 'IGFBP5', 'PRKCD', 'FOS', 'ACTA2', 'CREB3', 'ACTC1', 'PRKAR1A', 'MAFF', 'CRH', 'CALM3', 'PRKD1']",0.9702574866833555,0,0,25
149,Photodynamic therapy-induced NF-kB survival signaling WP3617,0.259083092322258,1.719690713910367,2.322625368419156,"['CCND1', 'PTGS2', 'BCL2L2', 'VEGFA']",0.9702574866833555,0,0,4
150,Pyrimidine metabolism WP4022,0.261889173273672,1.241167267532821,1.6629579402532895,"['NME2', 'NME1', 'NT5C', 'POLE4', 'POLD4', 'POLD1', 'POLE2', 'POLR1C', 'DPYD', 'POLE3', 'POLR2E', 'POLR1E', 'POLR2I', 'DCTPP1', 'POLR2K', 'POLR2L']",0.9739728927709768,0,0,16
151,miRNA regulation of DNA damage response WP1530,0.26423782733282136,1.2903140769752204,1.7172863859763672,"['CDKN1A', 'CDKN1B', 'CASP8', 'CCND1', 'CCNE2', 'GADD45B', 'GADD45A', 'CHEK2', 'CYCS', 'BAX', 'GADD45G', 'RAD9A']",0.9739728927709768,0,0,12
152,Sudden Infant Death Syndrome (SIDS) Susceptibility Pathways WP706,0.2700635475331787,1.1832084893882646,1.5489358510002957,"['CHRNB2', 'EGR1', 'VIPR1', 'DLX2', 'JUN', 'CEBPB', 'CAV3', 'CDCA7L', 'ATP1A3', 'SSTR1', 'ASCL1', 'GCK', 'VEGFA', 'PRKAR1A', 'SST', 'KCNQ1', 'PAH', 'CHRFAM7A', 'TAC1', 'ALDOA', 'GAPDH', 'SLC25A4', 'YWHAG']",0.9739728927709768,0,0,23
153,ApoE and miR-146 in inflammation and atherosclerosis WP3926,0.28253571588035153,2.3640676567656764,2.988064044064758,"['APOE', 'TLR4']",0.9739728927709768,0,0,2
154,Biogenic Amine Synthesis WP550,0.28253571588035153,2.3640676567656764,2.988064044064758,"['GAD1', 'PAH']",0.9739728927709768,0,0,2
155,Cellular Proteostasis WP4918,0.28253571588035153,2.3640676567656764,2.988064044064758,"['VBP1', 'PFDN5']",0.9739728927709768,0,0,2
156,Classical pathway of steroidogenesis with glucocorticoid and mineralocorticoid metabolism WP4523,0.28253571588035153,2.3640676567656764,2.988064044064758,"['HSD11B1', 'STAR']",0.9739728927709768,0,0,2
157,Irinotecan pathway WP229,0.28253571588035153,2.3640676567656764,2.988064044064758,"['ABCC2', 'CYP3A5']",0.9739728927709768,0,0,2
158,Methionine metabolism leading to sulfur amino acids and related disorders WP4292,0.28253571588035153,2.3640676567656764,2.988064044064758,"['AHCY', 'MAT2B']",0.9739728927709768,0,0,2
159,Methylation Pathways WP704,0.28253571588035153,2.3640676567656764,2.988064044064758,"['NNMT', 'MAT2B']",0.9739728927709768,0,0,2
160,Peroxiredoxin 2 induced ovarian failure WP4873,0.28253571588035153,2.3640676567656764,2.988064044064758,"['STAR', 'BAX']",0.9739728927709768,0,0,2
161,PTF1A related regulatory pathway WP4147,0.28253571588035153,2.3640676567656764,2.988064044064758,"['NOTCH1', 'FGF10']",0.9739728927709768,0,0,2
162,Breast cancer pathway WP4262,0.28487188703305844,1.1703828995118108,1.4696682041186975,"['SHC4', 'JUN', 'CDKN1A', 'NOTCH1', 'SHC3', 'WNT5B', 'GADD45B', 'GADD45A', 'EGF', 'NOTCH4', 'TCF7', 'FOS', 'FGF1', 'WNT16', 'GADD45G', 'DLL3', 'SFRP4', 'FRAT2', 'CCND1', 'HEY1', 'BAX', 'HRAS', 'FGF10']",0.9739728927709768,0,0,23
163,Acute viral myocarditis WP4298,0.285528741697528,1.2615299640983153,1.5812175314734387,"['CASP7', 'EDN1', 'CD4', 'SGCD', 'CASP8', 'ENDOG', 'TGFB1', 'CCND1', 'CYCS', 'BAX', 'TLR4', 'SGCG']",0.9739728927709768,0,0,12
164,Pathways in clear cell renal cell carcinoma WP4018,0.2862572659756993,1.2235944450006435,1.5305506592372373,"['PDGFRB', 'TPI1', 'TGFB1', 'BHLHE41', 'ENO2', 'ACACB', 'VEGFA', 'ACLY', 'LDHA', 'PKM', 'PGK1', 'ALDOC', 'ALDOA', 'GAPDH', 'PFKM']",0.9739728927709768,0,0,15
165,Bone morphogenic protein (BMP) signaling and regulation WP1425,0.2989324707514749,1.773163433759802,2.1411614842806386,"['BMP2', 'BMPR1B', 'RUNX2']",0.9768164807498321,0,0,3
166,Cancer immunotherapy by PD-1 blockade WP4585,0.2989324707514749,1.773163433759802,2.1411614842806386,"['JUN', 'HLA-A', 'PDCD1LG2']",0.9768164807498321,0,0,3
167,Glutathione metabolism WP100,0.2989324707514749,1.773163433759802,2.1411614842806386,"['GPX2', 'GSTM2', 'GPX4']",0.9768164807498321,0,0,3
168,Inflammatory Response Pathway WP453,0.2989324707514749,1.773163433759802,2.1411614842806386,"['IL5', 'LAMB2', 'FN1']",0.9768164807498321,0,0,3
169,RalA downstream regulated genes WP2290,0.2989324707514749,1.773163433759802,2.1411614842806386,"['EXOC8', 'YBX3', 'HRAS']",0.9768164807498321,0,0,3
170,Microglia Pathogen Phagocytosis Pathway WP3937,0.2993469860362389,1.4778242461792648,1.7824805076496262,"['C1QB', 'C1QA', 'HCK', 'PLCG2', 'PTPN6']",0.9768164807498321,0,0,5
171,"Oligodendrocyte specification and differentiation, leading to myelin components for CNS WP4304",0.2993469860362389,1.4778242461792648,1.7824805076496262,"['BMP2', 'OMG', 'SOX8', 'ASCL1', 'GLI2']",0.9768164807498321,0,0,5
172,miRNA targets in ECM and membrane receptors WP2911,0.3013990349197579,1.576245527112579,1.8904230926078212,"['COL5A1', 'LAMB2', 'COL5A3', 'FN1']",0.9777945435187494,0,0,4
173,Cholesterol metabolism (includes both Bloch and Kandutsch-Russell pathways) WP4718,0.3058180981880211,1.2899537367886562,1.5282917863307415,"['IDI1', 'SQLE', 'HMGCS1', 'CYP51A1', 'MSMO1', 'DHCR24', 'HMGCR', 'DHCR7', 'FDFT1']",0.9863959467567386,0,0,9
174,COVID-19 adverse outcome pathway WP4891,0.31879986100882085,4.727422680412372,5.4043506923333915,['IL7'],0.9999787993408132,0,0,1
175,Primary focal segmental glomerulosclerosis (FSGS) WP2572,0.32949294745009977,1.2076363059458126,1.3407182242482152,"['MYO1E', 'CDKN1A', 'CDKN1B', 'INF2', 'NOTCH1', 'TGFB1', 'ITGB4', 'LAMB2', 'FAT1', 'VIM', 'DKK1', 'TLR4']",0.9999787993408132,0,0,12
176,TGF-beta receptor signaling in skeletal dysplasias WP4816,0.33198325847964893,1.2519044026381756,1.3804383510657467,"['TGFBR3', 'JUN', 'TGFB1', 'EGF', 'FST', 'FOS', 'HRAS', 'RUNX2', 'TGFBR2']",0.9999787993408132,0,0,9
177,Physiological and pathological hypertrophy of the heart WP1528,0.3365878323199492,1.3907719221517603,1.5144061869152283,"['MAPK11', 'EDN1', 'JUN', 'FOS', 'IL6ST']",0.9999787993408132,0,0,5
178,Aryl Hydrocarbon Receptor Netpath WP2586,0.34130016553283693,1.2610973256134546,1.3556707192442792,"['CDKN1A', 'HSP90AA1', 'CDKN1B', 'AIP', 'AHR', 'PTGS2', 'HRAS', 'VEGFA']",0.9999787993408132,0,0,8
179,Apoptosis Modulation by HSP70 WP384,0.3443889852145747,1.454868830591374,1.5508661527637935,"['CASP7', 'CASP8', 'CYCS', 'FADD']",0.9999787993408132,0,0,4
180,Constitutive Androstane Receptor Pathway WP2875,0.3443889852145747,1.454868830591374,1.5508661527637935,"['HSP90AA1', 'ABCB1', 'ABCC2', 'CYP3A5']",0.9999787993408132,0,0,4
181,Nucleotide metabolism WP404,0.3443889852145747,1.454868830591374,1.5508661527637935,"['PRPS1', 'POLD1', 'NME2', 'OAZ1']",0.9999787993408132,0,0,4
182,Proteoglycan biosynthesis WP4784,0.3443889852145747,1.454868830591374,1.5508661527637935,"['CSGALNACT1', 'B4GALT7', 'PAPSS2', 'CHST3']",0.9999787993408132,0,0,4
183,Regulation of apoptosis by parathyroid hormone-related protein WP3872,0.3443889852145747,1.454868830591374,1.5508661527637935,"['ITGB4', 'BAX', 'BCL2L14', 'BCL2L2']",0.9999787993408132,0,0,4
184,ID signaling pathway WP53,0.3510233478430594,1.5760077039482734,1.6499264677826118,"['PAX8', 'ID3', 'ELK3']",0.9999787993408132,0,0,3
185,IL1 and megakaryocytes in obesity WP2865,0.3510233478430594,1.5760077039482734,1.6499264677826118,"['IL1R1', 'IL18', 'TIMP2']",0.9999787993408132,0,0,3
186,Overview of nanoparticle effects WP3287,0.3510233478430594,1.5760077039482734,1.6499264677826118,"['FN1', 'BAX', 'PTGS2']",0.9999787993408132,0,0,3
187,Parkinson's disease pathway WP2371,0.3513259720967173,1.273142112125163,1.3317585820926159,"['MAPK11', 'CASP7', 'PINK1', 'CCNE2', 'HTRA2', 'CYCS', 'UBE2L6']",0.9999787993408132,0,0,7
188,Aspirin and miRNAs WP4707,0.35264359685074453,1.891089108910891,1.9710772098137501,"['PTGS2', 'VEGFA']",0.9999787993408132,0,0,2
189,Dual hijack model of Vif in HIV infection WP3300,0.35264359685074453,1.891089108910891,1.9710772098137501,"['ELOB', 'RUNX1']",0.9999787993408132,0,0,2
190,Ketogenesis and Ketolysis WP4742,0.35264359685074453,1.891089108910891,1.9710772098137501,"['CPT2', 'BDH1']",0.9999787993408132,0,0,2
191,Sulfation Biotransformation Reaction WP692,0.35264359685074453,1.891089108910891,1.9710772098137501,"['SULT4A1', 'PAPSS2']",0.9999787993408132,0,0,2
192,Head and Neck Squamous Cell Carcinoma WP4674,0.36410817860727285,1.160037219776525,1.1719905466652307,"['CDKN1A', 'NOTCH1', 'CDKN2A', 'RPS6', 'GAB1', 'TGFBR2', 'VEGFA', 'CASP8', 'CCND1', 'FAT1', 'FADD', 'HRAS', 'FGFR3']",0.9999787993408132,0,0,13
193,Endometrial cancer WP4155,0.3747566867611067,1.1581421300914732,1.1366913677267896,"['CDKN1A', 'CCND1', 'GADD45B', 'EGF', 'GADD45A', 'TCF7', 'BAX', 'FOS', 'FGF1', 'HRAS', 'FGFR3', 'GADD45G']",0.9999787993408132,0,0,12
194,ncRNAs involved in Wnt signaling in hepatocellular carcinoma WP4336,0.3747566867611067,1.1581421300914732,1.1366913677267896,"['SFRP4', 'JUN', 'FRAT2', 'SFRP2', 'CCND1', 'WNT5B', 'TCF7', 'ROR2', 'NOTUM', 'WNT16', 'DKK1', 'CXXC4']",0.9999787993408132,0,0,12
195,Fas ligand pathway and stress induction of heat shock proteins WP314,0.3821756027887968,1.2258815243519667,1.179144892785261,"['CASP7', 'JUN', 'CASP8', 'HSPB1', 'CYCS', 'FADD', 'ACTG1']",0.9999787993408132,0,0,7
196,Chromosomal and microsatellite instability in colorectal cancer  WP4216,0.3859762519585342,1.138455280809197,1.0837860148078802,"['CDKN1A', 'JUN', 'TGFB1', 'GADD45B', 'GADD45A', 'TCF7', 'FOS', 'PTGS2', 'TGFBR2', 'GADD45G', 'CCND1', 'CYCS', 'BAX']",0.9999787993408132,0,0,13
197,One-carbon metabolism WP241,0.38747809189142135,1.3508316621446266,1.2807180534626639,"['AHCY', 'CHDH', 'GLRX', 'MAT2B']",0.9999787993408132,0,0,4
198,Parkin-Ubiquitin Proteasomal System pathway WP2359,0.3976702495305067,1.1348798674399336,1.0465091961257835,"['PSMD8', 'TUBB8', 'TUBA1C', 'HSPA8', 'TUBB6', 'CASP8', 'TUBB2A', 'HSPA5', 'UBE2L6', 'STUB1', 'HSPA1B', 'TUBA8']",0.9999787993408132,0,0,12
199,G1 to S cell cycle control WP45,0.3986126807662008,1.1532870295590374,1.0607531121491751,"['CREB3', 'CDKN1A', 'CDKN1B', 'CDKN2C', 'CCND1', 'CCNE2', 'CDKN2A', 'GADD45A', 'RPA3', 'POLE2']",0.9999787993408132,0,0,10
200,miRNAs involved in DNA damage response WP1545,0.40261955214580586,1.4182831200990507,1.2903017930549834,"['CDKN1A', 'CDKN1B', 'CCND1']",0.9999787993408132,0,0,3
201,Type II diabetes mellitus WP1584,0.40261955214580586,1.4182831200990507,1.2903017930549834,"['SURF1', 'KCNJ11', 'PRKCD']",0.9999787993408132,0,0,3
202,Intracellular trafficking proteins involved in CMT neuropathy WP4856,0.4116999975306303,1.2441574816843843,1.1041404418698204,"['RAB3B', 'RAB3A', 'SH3TC2', 'HSPB1', 'RAB11A']",0.9999787993408132,0,0,5
203,"Degradation pathway of sphingolipids, including diseases WP4153",0.4201560121357793,1.5757700770077008,1.3663962135022443,"['NEU1', 'GLA']",0.9999787993408132,0,0,2
204,Nephrogenesis WP5052,0.4201560121357793,1.5757700770077008,1.3663962135022443,"['MEIS1', 'ALDH1A2']",0.9999787993408132,0,0,2
205,Alpha 6 Beta 4 signaling pathway WP244,0.4296664864047727,1.1819214876033057,0.9984234303517712,"['LAMB3', 'ITGB4', 'LAMB2', 'PRKCD', 'GAB1', 'HRAS']",0.9999787993408132,0,0,6
206,let-7 inhibition of ES cell reprogramming WP3299,0.437785330983057,2.363505154639175,1.9523181285304507,['EGR1'],0.9999787993408132,0,0,1
207,MED and Pseudoachondroplasia genes WP4789,0.437785330983057,2.363505154639175,1.9523181285304507,['COL9A2'],0.9999787993408132,0,0,1
208,Nanomaterial-induced inflammasome activation WP3890,0.437785330983057,2.363505154639175,1.9523181285304507,['TLR4'],0.9999787993408132,0,0,1
209,SARS-CoV-2 altering angiogenesis via NRP1 WP5065,0.437785330983057,2.363505154639175,1.9523181285304507,['VEGFA'],0.9999787993408132,0,0,1
210,Steroid Biosynthesis WP496,0.437785330983057,2.363505154639175,1.9523181285304507,['HSD17B1'],0.9999787993408132,0,0,1
211,Corticotropin-releasing hormone signaling pathway WP2355,0.4385006278755079,1.0851208438680913,0.8945671512642909,"['HSP90AA1', 'TGFB1', 'PRKCD', 'IL18', 'FOS', 'FOSL2', 'CRHBP', 'NR4A1', 'STAR', 'CRH', 'PLCG2', 'FOSB', 'JUNB', 'TLR4']",0.9999787993408132,0,0,14
212,Endochondral Ossification with Skeletal Dysplasias WP4808,0.43901862508443795,1.119733031378612,0.9217792813666988,"['GHR', 'ADAMTS5', 'TGFB1', 'HMGCS1', 'TIMP3', 'FGFR3', 'GLI3', 'RUNX2', 'VEGFA']",0.9999787993408132,0,0,9
213,Endochondral Ossification WP474,0.43901862508443795,1.119733031378612,0.9217792813666988,"['GHR', 'ADAMTS5', 'TGFB1', 'HMGCS1', 'TIMP3', 'FGFR3', 'GLI3', 'RUNX2', 'VEGFA']",0.9999787993408132,0,0,9
214,Hedgehog Signaling Pathway WP4249,0.4438996889315526,1.1411384014483044,0.9267831617385033,"['EVC', 'CCND1', 'HHIP', 'GAS1', 'LRP2', 'GLI3', 'GLI2']",0.9999787993408132,0,0,7
215,Hepatitis C and Hepatocellular Carcinoma WP3646,0.4438996889315526,1.1411384014483044,0.9267831617385033,"['CDKN1A', 'CASP7', 'JUN', 'TGFB1', 'CCND1', 'PTGS2', 'VEGFA']",0.9999787993408132,0,0,7
216,Cell cycle WP179,0.44787209842205844,1.063797757475083,0.854492976346025,"['CDKN1A', 'TGFB1', 'CDKN1B', 'CDKN2C', 'GADD45B', 'GADD45A', 'CDKN2A', 'CDC14A', 'ANAPC11', 'GADD45G', 'SMC1B', 'CCNA2', 'CCND1', 'PTTG1', 'CCNE2', 'CHEK2', 'BUB3', 'YWHAG']",0.9999787993408132,0,0,18
217,Extracellular vesicle-mediated signaling in recipient cells WP2870,0.4488842253531647,1.1818463444857497,0.946647427865023,"['TGFBR3', 'TGFB1', 'PROM1', 'HRAS', 'TGFBR2']",0.9999787993408132,0,0,5
218,Small cell lung cancer WP4658,0.45348566062835927,1.0654199053240605,0.8425251427867779,"['CDKN1A', 'CDKN1B', 'LAMB3', 'GADD45B', 'LAMB2', 'GADD45A', 'LAMB4', 'FN1', 'PTGS2', 'CKS1B', 'GADD45G', 'CASP8', 'CCND1', 'CCNE2', 'CYCS', 'BAX']",0.9999787993408132,0,0,16
219,Vitamin A and carotenoid metabolism WP716,0.4630305551702339,1.1345454545454545,0.8735571518319469,"['CYP26A1', 'ALDH1A3', 'RBP4', 'RBP2', 'ALDH1A2', 'BCO1']",0.9999787993408132,0,0,6
220,The Overlap Between Signal Transduction Pathways that Contribute to a Range of LMNA Laminopathies WP4879,0.4657309581086731,1.090926450463066,0.8336283431057455,"['CDKN1A', 'CEBPB', 'BMP2', 'NOTCH1', 'TGFB1', 'MSTN', 'TCF7', 'JUNB', 'RUNX2']",0.9999787993408132,0,0,9
221,SARS-CoV-2 innate immunity evasion and cell-specific immune response WP5039,0.4744098772955376,1.1030039961416562,0.8224920026902529,"['MAVS', 'CASP8', 'TGFB1', 'TRADD', 'CXCL17', 'FADD', 'IFIT2']",0.9999787993408132,0,0,7
222,Endoplasmic reticulum stress response in coronavirus infection WP4861,0.48395119110803914,1.0804679191775965,0.7841725222156902,"['PPP1R15A', 'PPP1CC', 'PPP1R14B', 'XBP1', 'MAP1LC3A', 'PPP1R11', 'HSPA5', 'DDIT3']",0.9999787993408132,0,0,8
223,Oxysterols derived from cholesterol WP4545,0.4854221666936394,1.1254696013060326,0.8134177577765808,"['CYP39A1', 'INSIG1', 'ACOT11', 'DHCR7', 'ACOT6']",0.9999787993408132,0,0,5
224,T-cell receptor (TCR) signaling pathway WP69,0.4893468840302773,1.0504464696676792,0.7507369346133682,"['MAP4K1', 'JUN', 'CD4', 'TGFB1', 'FYB1', 'PRKCD', 'PTK2B', 'FOS', 'CD247', 'VIM', 'HRAS', 'CARD11']",0.9999787993408132,0,0,12
225,Eicosanoid metabolism via lipooxygenases (LOX) WP4721,0.5014175476197604,1.1816962443252166,0.8157439387767662,"['HPGD', 'TRPA1', 'ALOX12']",0.9999787993408132,0,0,3
226,Eicosanoid Synthesis WP167,0.5014175476197604,1.1816962443252166,0.8157439387767662,"['PTGES2', 'ALOX12', 'PTGS2']",0.9999787993408132,0,0,3
227,PPAR-alpha pathway WP2878,0.5014175476197604,1.1816962443252166,0.8157439387767662,"['CCND1', 'CPT2', 'APOA1']",0.9999787993408132,0,0,3
228,SREBF and miR33 in cholesterol and lipid homeostasis WP2011,0.5014175476197604,1.1816962443252166,0.8157439387767662,"['HMGCS1', 'HMGCR', 'LDLR']",0.9999787993408132,0,0,3
229,Angiogenesis WP1539,0.5126132231004497,1.1121581580609121,0.7431815267436555,"['ANGPT1', 'TIMP2', 'TIMP3', 'VEGFA']",0.9999787993408132,0,0,4
230,Gastric Cancer Network 1 WP2361,0.5126132231004497,1.1121581580609121,0.7431815267436555,"['NOTCH1', 'GATD3B', 'GATD3A', 'KIF15']",0.9999787993408132,0,0,4
231,Hypothesized Pathways in Pathogenesis of Cardiovascular Disease WP3668,0.5126132231004497,1.1121581580609121,0.7431815267436555,"['TGFBR3', 'ANGPT2', 'RUNX2', 'TGFBR2']",0.9999787993408132,0,0,4
232,IL-7 signaling pathway WP205,0.5126132231004497,1.1121581580609121,0.7431815267436555,"['CDKN1B', 'CCND1', 'IL7', 'PTK2B']",0.9999787993408132,0,0,4
233,NRF2-ARE regulation WP4357,0.5126132231004497,1.1121581580609121,0.7431815267436555,"['AIMP2', 'CEBPB', 'SLC7A11', 'EPHB2']",0.9999787993408132,0,0,4
234,Type II interferon signaling (IFNG) WP619,0.5126132231004497,1.1121581580609121,0.7431815267436555,"['CIITA', 'PRKCD', 'HLA-B', 'IFIT2']",0.9999787993408132,0,0,4
235,"Non-genomic actions of 1,25 dihydroxyvitamin D3 WP4341",0.5182881275545717,1.0375288858391274,0.6818888435479791,"['IFI27L2', 'MAPK11', 'JUN', 'PRKCH', 'PRKCD', 'PLCG2', 'ETS1', 'HRAS', 'TLR4']",0.9999787993408132,0,0,9
236,Neovascularisation processes WP4331,0.5210633981528512,1.0742180165971988,0.7002650639277836,"['NOTCH1', 'TGFB1', 'ANGPT1', 'NOTCH4', 'EPHB2']",0.9999787993408132,0,0,5
237,p38 MAPK Signaling Pathway WP400,0.5279848105209948,1.0503213957759412,0.6708274233738396,"['RPS6KA5', 'TRADD', 'DDIT3', 'HSPB1', 'HRAS', 'HMGN1']",0.9999787993408132,0,0,6
238,Effects of nitric oxide WP1995,0.5359946022125577,1.57553264604811,0.9825512965140907,['AOX1'],0.9999787993408132,0,0,1
239,Gene regulatory network modelling somitogenesis  WP2854,0.5359946022125577,1.57553264604811,0.9825512965140907,['NOTCH1'],0.9999787993408132,0,0,1
240,Macrophage markers WP4146,0.5359946022125577,1.57553264604811,0.9825512965140907,['CD74'],0.9999787993408132,0,0,1
241,Synthesis and Degradation of Ketone Bodies WP311,0.5359946022125577,1.57553264604811,0.9825512965140907,['BDH1'],0.9999787993408132,0,0,1
242,Vitamin B6-dependent and responsive disorders WP4228,0.5359946022125577,1.57553264604811,0.9825512965140907,['PNPO'],0.9999787993408132,0,0,1
243,Calcium Regulation in the Cardiac Cell WP536,0.5374649993296873,0.9997040189427877,0.6207078664631056,"['RYR1', 'KCNJ5', 'PRKCH', 'RGS16', 'CHRM5', 'PRKCD', 'ADRA1D', 'ATP1B2', 'ATP1B1', 'RGS4', 'GJD2', 'RGS5', 'RGS2', 'PLN', 'PRKAR1A', 'GNG4', 'GJA9', 'CALM3', 'PRKD1', 'CALR', 'CASQ1', 'YWHAG']",0.9999787993408132,0,0,22
244,Cysteine and methionine catabolism WP4504,0.5429767744012916,1.1816212871287128,0.7216028063734328,"['AHCY', 'GOT1']",0.9999787993408132,0,0,2
245,Ethanol metabolism resulting in production of ROS by CYP2E1 WP4269,0.5429767744012916,1.1816212871287128,0.7216028063734328,"['MAFF', 'MAFK']",0.9999787993408132,0,0,2
246,Simplified Depiction of MYD88 Distinct Input-Output Pathway WP3877,0.5429767744012916,1.1816212871287128,0.7216028063734328,"['JUN', 'TLR4']",0.9999787993408132,0,0,2
247,Transcriptional cascade regulating adipogenesis WP4211,0.5429767744012916,1.1816212871287128,0.7216028063734328,"['CEBPB', 'DDIT3']",0.9999787993408132,0,0,2
248,BMP Signaling Pathway in Eyelid Development WP3927,0.5475756386807701,1.0907012921045112,0.6568799510991831,"['JUN', 'NOTCH1', 'FGF10']",0.9999787993408132,0,0,3
249,Glycosaminoglycan degradation WP4815,0.5475756386807701,1.0907012921045112,0.6568799510991831,"['HYAL2', 'IDS', 'SGSH']",0.9999787993408132,0,0,3
250,Methionine De Novo and Salvage Pathway WP3580,0.5475756386807701,1.0907012921045112,0.6568799510991831,"['AHCY', 'CHDH', 'MAT2B']",0.9999787993408132,0,0,3
251,7-oxo-C and 7beta-HC pathways WP5064,0.5517299539748504,1.0502798421873567,0.6245978157218859,"['HSD11B1', 'ACOT11', 'DHCR7', 'ACOT6']",0.9999787993408132,0,0,4
252,SARS-CoV-2 mitochondrial interactions WP5038,0.5517299539748504,1.0502798421873567,0.6245978157218859,"['NDUFB9', 'MAVS', 'PHB', 'TMEM173']",0.9999787993408132,0,0,4
253,Apoptosis WP254,0.5523245159864136,0.9997053670966715,0.5934446143247558,"['CASP7', 'JUN', 'CASP8', 'CRADD', 'CDKN2A', 'TRADD', 'CYCS', 'BAX', 'FADD', 'NFKBIE', 'BCL2L2']",0.9999787993408132,0,0,11
254,Melanoma WP4685,0.5523245159864136,0.9997053670966715,0.5934446143247558,"['CDKN1A', 'CCND1', 'GADD45B', 'CDKN2A', 'GADD45A', 'BAX', 'CALM3', 'FOS', 'ETS1', 'HRAS', 'GADD45G']",0.9999787993408132,0,0,11
255,LncRNA involvement in canonical Wnt signaling and colorectal cancer WP4258,0.5561019549429629,0.9948981816596172,0.5838098638242246,"['SFRP4', 'JUN', 'FRAT2', 'SFRP2', 'CCND1', 'WNT5B', 'TCF7', 'ROR2', 'NOTUM', 'WNT16', 'DKK1', 'CXXC4']",0.9999787993408132,0,0,12
256,ATM Signaling Pathway WP2516,0.5592296232864866,1.0127213695395514,0.5885887128953287,"['CDKN1A', 'JUN', 'CRADD', 'GADD45A', 'CHEK2', 'RAD9A']",0.9999787993408132,0,0,6
257,Signaling of Hepatocyte Growth Factor Receptor WP313,0.5592296232864866,1.0127213695395514,0.5885887128953287,"['MAP4K1', 'JUN', 'GAB1', 'PTK2B', 'FOS', 'HRAS']",0.9999787993408132,0,0,6
258,Hepatitis B infection WP4666,0.5638111090473481,0.9844312829038515,0.564114561299358,"['JUN', 'CDKN1A', 'TICAM2', 'TGFB1', 'EGR3', 'ATP6AP1', 'SLC10A1', 'FOS', 'TGFBR2', 'CREB3', 'MAPK11', 'MAVS', 'CASP8', 'CYCS', 'PTK2B', 'BAX', 'STAT6', 'FADD', 'HRAS', 'TLR4']",0.9999787993408132,0,0,20
259,Modulators of TCR signaling and T cell activation WP5072,0.5659251910298555,0.9949066213921901,0.5663937541121604,"['MAP4K1', 'CDKN1B', 'NDUFB10', 'ELOB', 'PTPN6', 'CD247', 'CARD11', 'ZFP36L1']",0.9999787993408132,0,0,8
260,Gastrin signaling pathway WP4659,0.5722574020051296,0.9796140489424819,0.5467876327050336,"['EGR1', 'JUN', 'CDKN1A', 'PRKCH', 'CDKN1B', 'ANXA2', 'CDKN2A', 'RPS6', 'PRKCD', 'FOS', 'PTGS2', 'VEGFA', 'BMP2', 'CCND1', 'KAT5', 'PRKD1', 'HRAS']",0.9999787993408132,0,0,17
261,Sterol regulatory element-binding proteins (SREBP) signaling WP1982,0.5748780427285146,0.9807570608226884,0.5429445199510128,"['ACLY', 'IDI1', 'SQLE', 'RBP4', 'HMGCS1', 'INSIG1', 'CYP51A1', 'HMGCR', 'ACSS1', 'LDLR', 'FDFT1']",0.9999787993408132,0,0,11
262,Androgen receptor signaling pathway WP138,0.5828706580272754,0.9728197249048873,0.5251183331533003,"['CDKN1A', 'JUN', 'RNF6', 'ETV5', 'RUNX2', 'PSMC3IP', 'CCND1', 'KAT5', 'BAG1', 'STUB1', 'CALR', 'FKBP4', 'RAN', 'RAD9A']",0.9999787993408132,0,0,14
263,PDGFR-beta pathway WP3972,0.5888498934946736,0.9845277433567396,0.5213901183496027,"['PDGFRB', 'JUN', 'STAT6', 'FOS', 'HRAS']",0.9999787993408132,0,0,5
264,Tumor suppressor activity of SMARCB1 WP4204,0.5888498934946736,0.9845277433567396,0.5213901183496027,"['H3F3B', 'CDKN2A', 'DPF3', 'GLI3', 'GLI2']",0.9999787993408132,0,0,5
265,Cannabinoid receptor signaling WP3869,0.5891132969208052,0.9949150332478596,0.5264461162966099,"['MAPK11', 'ADORA2A', 'PRKAR1A', 'AHR']",0.9999787993408132,0,0,4
266,Hair Follicle Development: Organogenesis - Part 2 of 3 WP2839,0.5891132969208052,0.9949150332478596,0.5264461162966099,"['CCND1', 'FGF1', 'RUNX2', 'GLI2']",0.9999787993408132,0,0,4
267,Alanine and aspartate metabolism WP106,0.5972088024020357,1.0502383571690503,0.5413857680434588,"['GOT1', 'GAD1']",0.9999787993408132,0,0,2
268,Homologous recombination WP186,0.5972088024020357,1.0502383571690503,0.5413857680434588,"['POLD4', 'POLD1']",0.9999787993408132,0,0,2
269,Mammary gland development pathway - Embryonic development (Stage 1 of 4) WP2813,0.5972088024020357,1.0502383571690503,0.5413857680434588,"['TGFB1', 'CCND1']",0.9999787993408132,0,0,2
270,Pathways of nucleic acid metabolism and innate immune sensing WP4705,0.5972088024020357,1.0502383571690503,0.5413857680434588,"['MAVS', 'TMEM173']",0.9999787993408132,0,0,2
271,Serotonin and anxiety-related events WP3944,0.5972088024020357,1.0502383571690503,0.5413857680434588,"['CRH', 'FOS']",0.9999787993408132,0,0,2
272,Non-small cell lung cancer WP4255,0.5987192802312622,0.9610043110106301,0.49295911437789275,"['CDKN1A', 'CASP8', 'CCND1', 'GADD45B', 'CDKN2A', 'EGF', 'GADD45A', 'PLCG2', 'CYCS', 'BAX', 'HRAS', 'GADD45G']",0.9999787993408132,0,0,12
273,PI3K-Akt signaling pathway WP4172,0.5987288716180242,0.968899778623165,0.49699367119957266,"['CDKN1A', 'CDKN1B', 'ITGB4', 'FGF1', 'THBS4', 'GYS2', 'GHR', 'RELN', 'CCND1', 'GNG4', 'PDGFD', 'NTF3', 'HRAS', 'PCK2', 'PDGFRB', 'HSP90AA1', 'ANGPT2', 'ANGPT1', 'LAMB3', 'EGF', 'LAMB2', 'RPS6', 'LAMB4', 'FN1', 'VEGFB', 'VEGFC', 'PRLR', 'EPOR', 'VEGFA', 'CREB3', 'CCNE2', 'LPAR6', 'IL7', 'COL6A6', 'COL9A2', 'FGFR4', 'SGK2', 'TLR4', 'FGFR3', 'FGF10']",0.9999787993408132,0,0,40
274,Eicosanoid metabolism via cytochrome P450 monooxygenases (CYP) pathway WP4720,0.6170541910463513,1.1815463917525773,0.5704487417721577,['CYP2C18'],0.9999787993408132,0,0,1
275,EV release from cardiac cells and their functional effects WP3297,0.6170541910463513,1.1815463917525773,0.5704487417721577,['RGS16'],0.9999787993408132,0,0,1
276,FOXP3 in COVID-19 WP5063,0.6170541910463513,1.1815463917525773,0.5704487417721577,['IL6ST'],0.9999787993408132,0,0,1
277,FTO Obesity Variant Mechanism WP3407,0.6170541910463513,1.1815463917525773,0.5704487417721577,['PRDM16'],0.9999787993408132,0,0,1
278,Mitochondrial fatty acid synthesis pathway WP4317,0.6170541910463513,1.1815463917525773,0.5704487417721577,['HSD17B12'],0.9999787993408132,0,0,1
279,Tgif disruption of Shh signaling WP3674,0.6170541910463513,1.1815463917525773,0.5704487417721577,['GLI3'],0.9999787993408132,0,0,1
280,The alternative pathway of fetal androgen synthesis WP4524,0.6170541910463513,1.1815463917525773,0.5704487417721577,['STAR'],0.9999787993408132,0,0,1
281,Vitamin D Metabolism WP1531,0.6170541910463513,1.1815463917525773,0.5704487417721577,['DHCR7'],0.9999787993408132,0,0,1
282,Phosphodiesterases in neuronal function WP4222,0.6172025421329563,0.944995864350703,0.45601535181251424,"['ADCY10', 'PDE10A', 'ADORA2A', 'PDE3A', 'PDE6C', 'PDE5A', 'PDE6B', 'CHRFAM7A']",0.9999787993408132,0,0,8
283,Synaptic Vesicle Pathway WP2267,0.6172025421329563,0.944995864350703,0.45601535181251424,"['RAB3A', 'SLC32A1', 'SYN3', 'SLC25A4', 'CPLX1', 'SLC18A2', 'AP2M1', 'CPLX3']",0.9999787993408132,0,0,8
284,Association Between Physico-Chemical Features and Toxicity Associated Pathways WP3680,0.6173263940393584,0.9449731071576334,0.45581476467340193,"['CDKN1A', 'JUN', 'CDKN1B', 'TMSB4X', 'FN1', 'PFN4', 'WNT16', 'NEFH', 'PFN2']",0.9999787993408132,0,0,9
285,Nephrotic syndrome WP4758,0.6185769010717393,0.9450413223140496,0.45393525177983696,"['CUBN', 'MYO1E', 'INF2', 'ITGB4', 'LAMB2', 'GPC5']",0.9999787993408132,0,0,6
286,miRNA regulation of prostate cancer signaling pathways WP3981,0.6206865522734744,0.9450640231309376,0.4507285067931605,"['PDGFRB', 'CDKN1A', 'CDKN1B', 'CCND1', 'TCF7']",0.9999787993408132,0,0,5
287,ESC Pluripotency Pathways WP3931,0.6225166113726521,0.9448361675653256,0.4478381388188516,"['PDGFRB', 'JUN', 'WNT5B', 'EGF', 'GAB1', 'FOS', 'FGF1', 'WNT16', 'IL6ST', 'BMPR1B', 'FGFR4', 'FGFR3', 'HRAS', 'FGF10', 'ERAS']",0.9999787993408132,0,0,15
288,Ethanol effects on histone modifications WP3996,0.6245959303859692,0.9450867052023122,0.44480538830670435,"['ALDH1A3', 'AHCY', 'ALDH1A2', 'HAT1']",0.9999787993408132,0,0,4
289,FGFR3 signaling in chondrocyte proliferation and terminal differentiation WP4767,0.6245959303859692,0.9450867052023122,0.44480538830670435,"['MAPK11', 'CDKN1A', 'BMP2', 'FGFR3']",0.9999787993408132,0,0,4
290,TGF-beta Signaling Pathway WP366,0.6275399867851397,0.9447444952222683,0.44020170040250717,"['MAP4K1', 'YAP1', 'JUN', 'CDKN1A', 'TGFB1', 'CITED1', 'ITGB4', 'FN1', 'NEDD9', 'FOS', 'ETS1', 'RUNX2', 'TGFBR2', 'TGFBR3', 'PARD6A', 'CCND1', 'STRAP', 'FOSB', 'JUNB']",0.9999787993408132,0,0,19
291,Purinergic signaling WP4900,0.6318430765302151,0.9451093685513826,0.43391314327546876,"['ADORA2A', 'LPAR6', 'P2RY14']",0.9999787993408132,0,0,3
292,"Relationship between inflammation, COX-2 and EGFR WP4483",0.6318430765302151,0.9451093685513826,0.43391314327546876,"['PTGES2', 'PTGS2', 'HRAS']",0.9999787993408132,0,0,3
293,B Cell Receptor Signaling Pathway WP23,0.6395776633666342,0.9304838689422196,0.4158771798264198,"['MAP4K1', 'JUN', 'CD81', 'PRKCD', 'GAB1', 'ETS1', 'RASGRP3', 'TEC', 'PLCG2', 'PTPN6', 'HRAS', 'CARD11', 'CD22']",0.9999787993408132,0,0,13
294,EGFR Tyrosine Kinase Inhibitor Resistance WP4806,0.6395776633666342,0.9304838689422196,0.4158771798264198,"['PDGFRB', 'SHC4', 'SHC3', 'EGF', 'RPS6', 'GAB1', 'VEGFA', 'CCND1', 'PDGFD', 'PLCG2', 'BAX', 'HRAS', 'FGFR3']",0.9999787993408132,0,0,13
295,Thyroid stimulating hormone (TSH) signaling pathway WP2032,0.6396969443540841,0.9263407349694844,0.4138526715275928,"['EGR1', 'JUN', 'CDKN1B', 'PAX8', 'APEX1', 'RPS6', 'FOS', 'PLD1', 'HRAS', 'TSHR']",0.9999787993408132,0,0,10
296,Biomarkers for pyrimidine metabolism disorders WP4584,0.6464458507591806,0.9451320132013201,0.41232881335564175,"['NT5C', 'DPYD']",0.9999787993408132,0,0,2
297,Cell-type Dependent Selectivity of CCK2R Signaling WP3679,0.6464458507591806,0.9451320132013201,0.41232881335564175,"['RYR1', 'CCK']",0.9999787993408132,0,0,2
298,FOXA2 pathway WP5066,0.6464458507591806,0.9451320132013201,0.41232881335564175,"['GSTM2', 'ABCC2']",0.9999787993408132,0,0,2
299,Hedgehog Signaling Pathway Netpath WP47,0.6464458507591806,0.9451320132013201,0.41232881335564175,"['GLI3', 'GLI2']",0.9999787993408132,0,0,2
300,Copper homeostasis WP3286,0.6464801749930792,0.914476139696081,0.39890614838756944,"['PRNP', 'JUN', 'CCND1', 'SCO2', 'COX17', 'ATOX1']",0.9999787993408132,0,0,6
301,Ebola Virus Pathway on Host WP4217,0.6580960643894108,0.9216071247849408,0.38560444271937394,"['VPS18', 'GSN', 'CAV3', 'HLA-B', 'HLA-C', 'HLA-A', 'HLA-F', 'MERTK', 'ASGR1', 'ACTG1', 'HLA-E', 'VPS11', 'HLA-DRA', 'FLNC', 'TLR4', 'CLEC4G']",0.9999787993408132,0,0,16
302,NAD+ biosynthetic pathways WP3645,0.6696590256958873,0.885962649607924,0.35525916212060293,"['NMNAT1', 'TDO2', 'ACMSD']",0.9999787993408132,0,0,3
303,Serotonin Receptor 4/6/7 and NR3C Signaling WP734,0.6696590256958873,0.885962649607924,0.35525916212060293,"['EGR1', 'HTR7', 'RPS6KA5']",0.9999787993408132,0,0,3
304,Triacylglyceride synthesis WP325,0.6696590256958873,0.885962649607924,0.35525916212060293,"['MOGAT1', 'GPD1', 'AGPAT1']",0.9999787993408132,0,0,3
305,IL-6 signaling pathway WP364,0.6731076429105224,0.8858212809917355,0.3506523693502722,"['HCK', 'PRKCD', 'GAB1', 'VIP', 'IL6ST', 'JUNB']",0.9999787993408132,0,0,6
306,Integrated Cancer Pathway WP1971,0.6731076429105224,0.8858212809917355,0.3506523693502722,"['CDKN1A', 'CDKN1B', 'CASP8', 'CHEK2', 'BAX', 'BACH1']",0.9999787993408132,0,0,6
307,One-carbon metabolism and related pathways WP3940,0.6731076429105224,0.8858212809917355,0.3506523693502722,"['DMGDH', 'GPX2', 'GPX4', 'CHDH', 'GAD1', 'PLD1']",0.9999787993408132,0,0,6
308,IL-2 signaling pathway WP49,0.6797345855196748,0.8749062982850674,0.33776008954877546,"['JUN', 'RPS6', 'PTK2B', 'FOS', 'HRAS']",0.9999787993408132,0,0,5
309,Prostaglandin Synthesis and Regulation WP98,0.6797345855196748,0.8749062982850674,0.33776008954877546,"['HSD11B1', 'EDN1', 'HPGD', 'ANXA2', 'PTGS2']",0.9999787993408132,0,0,5
310,Neural Crest Differentiation WP2064,0.6814099022702205,0.8912282893914782,0.34186736609285007,"['NOTCH1', 'DLX5', 'NOTCH4', 'ZIC1', 'WNT8A', 'ASCL1', 'ETS1', 'FGFR3', 'GFAP', 'DLL3']",0.9999787993408132,0,0,10
311,Development of pulmonary dendritic cells and macrophage subsets WP3892,0.6839578178455512,0.9451546391752578,0.35902552734600973,['RUNX2'],0.9999787993408132,0,0,1
312,Folate-Alcohol and Cancer Pathway Hypotheses WP1589,0.6839578178455512,0.9451546391752578,0.35902552734600973,['CEBPB'],0.9999787993408132,0,0,1
313,Insulin signaling in adipocytes (diabetic condition) WP3635,0.6839578178455512,0.9451546391752578,0.35902552734600973,['RPS6'],0.9999787993408132,0,0,1
314,Insulin signaling in adipocytes (normal condition) WP3634,0.6839578178455512,0.9451546391752578,0.35902552734600973,['RPS6'],0.9999787993408132,0,0,1
315,mir-124 predicted interactions with cell cycle and differentiation  WP3595,0.6839578178455512,0.9451546391752578,0.35902552734600973,['STRADB'],0.9999787993408132,0,0,1
316,miRNA Biogenesis WP2338,0.6839578178455512,0.9451546391752578,0.35902552734600973,['RAN'],0.9999787993408132,0,0,1
317,Molybdenum cofactor (Moco) biosynthesis WP4507,0.6839578178455512,0.9451546391752578,0.35902552734600973,['AOX1'],0.9999787993408132,0,0,1
318,Osteoblast Signaling WP322,0.6839578178455512,0.9451546391752578,0.35902552734600973,['PDGFRB'],0.9999787993408132,0,0,1
319,Small Ligand GPCRs WP247,0.6839578178455512,0.9451546391752578,0.35902552734600973,['S1PR3'],0.9999787993408132,0,0,1
320,Somatic sex determination WP4814,0.6839578178455512,0.9451546391752578,0.35902552734600973,['SOX8'],0.9999787993408132,0,0,1
321,Tamoxifen metabolism WP691,0.6839578178455512,0.9451546391752578,0.35902552734600973,['CYP3A5'],0.9999787993408132,0,0,1
322,Urea cycle and related diseases WP4571,0.6839578178455512,0.9451546391752578,0.35902552734600973,['SLC25A15'],0.9999787993408132,0,0,1
323,Proteasome Degradation WP183,0.6841052944478776,0.8856795614398014,0.3362424300894149,"['PSMD8', 'PSMB6', 'H2AFZ', 'HLA-B', 'HLA-C', 'HLA-A', 'HLA-F', 'PSMB10', 'HLA-E']",0.9999787993408132,0,0,9
324,Notch Signaling Pathway Netpath WP61,0.6876219555088644,0.8788350933887318,0.3291378700488126,"['CDKN1A', 'NOTCH1', 'MAML2', 'CCND1', 'HEY1', 'NOTCH4', 'PSEN2', 'DLL3']",0.9999787993408132,0,0,8
325,Endothelin Pathways WP2197,0.6894543387873863,0.8590195931236394,0.31943056552585913,"['ADCY10', 'EDN1', 'NPY1R', 'RIIAD1']",0.9999787993408132,0,0,4
326,White fat cell differentiation WP4149,0.6894543387873863,0.8590195931236394,0.31943056552585913,"['CEBPB', 'DDIT3', 'EBF1', 'NR2F2']",0.9999787993408132,0,0,4
327,Fatty acid transporters WP5061,0.6907778602305321,0.8591359135913591,0.31782614759187827,"['FABP6', 'ACSL5']",0.9999787993408132,0,0,2
328,H19 action Rb-E2F1 signaling and CDK-Beta-catenin activity WP3969,0.6907778602305321,0.8591359135913591,0.31782614759187827,"['CCND1', 'TULP3']",0.9999787993408132,0,0,2
329,PI3K/AKT/mTOR - VitD3 signaling WP4141,0.6907778602305321,0.8591359135913591,0.31782614759187827,"['LDHA', 'HLA-DRA']",0.9999787993408132,0,0,2
330,Pyrimidine metabolism and related diseases WP4225,0.6907778602305321,0.8591359135913591,0.31782614759187827,"['NT5C', 'DPYD']",0.9999787993408132,0,0,2
331,22q11.2 copy number variation syndrome WP4657,0.6927718115898396,0.8934718300389942,0.3279529543181246,"['RANBP1', 'SERPIND1', 'SLC7A4', 'ACTA2', 'CLDN5', 'CYP26A1', 'MRPL40', 'RELN', 'ACTC1', 'THAP7', 'ALDH1A2', 'RCC1', 'RAN', 'FGF10']",0.9999787993408132,0,0,14
332,Wnt signaling WP428,0.6927718115898396,0.8934718300389942,0.3279529543181246,"['JUN', 'WNT5B', 'TCF7', 'WNT16', 'DKK1', 'CXXC4', 'SFRP4', 'FRAT2', 'SFRP2', 'PPP3R2', 'CCND1', 'ROR2', 'GPC4', 'NOTUM']",0.9999787993408132,0,0,14
333,Pancreatic adenocarcinoma pathway WP4263,0.6942186234859923,0.8897938100986804,0.32474657751183733,"['CDKN1A', 'TGFB1', 'GADD45B', 'CDKN2A', 'EGF', 'GADD45A', 'PRKCD', 'PLD1', 'TGFBR2', 'VEGFA', 'GADD45G', 'CCND1', 'BAX']",0.9999787993408132,0,0,13
334,Focal Adhesion-PI3K-Akt-mTOR-signaling pathway WP3932,0.6952907512578355,0.924014608401381,0.33581016962108673,"['CDKN1A', 'CRTC2', 'CDKN1B', 'EPAS1', 'ITGB4', 'COL11A1', 'HIF3A', 'FGF1', 'THBS4', 'GYS2', 'GHR', 'RELN', 'GNG4', 'PDGFD', 'PELO', 'HRAS', 'PDGFRB', 'HSP90AA1', 'ANGPT2', 'ANGPT1', 'LAMB3', 'EGF', 'LAMB2', 'RPS6', 'FN1', 'VEGFB', 'VEGFC', 'PRLR', 'EPOR', 'VEGFA', 'CREB3', 'COL5A1', 'LPAR6', 'COL5A3', 'FGFR4', 'FGFR3', 'FGF10']",0.9999787993408132,0,0,37
335,miRNA regulation of p53 pathway in prostate cancer WP3982,0.7045415652690991,0.8337743681872254,0.29199441200490445,"['CASP8', 'CHEK2', 'BAX']",0.9999787993408132,0,0,3
336,Monoamine Transport WP727,0.7045415652690991,0.8337743681872254,0.29199441200490445,"['TDO2', 'ADORA2A', 'IL1R1']",0.9999787993408132,0,0,3
337,Urea cycle and associated pathways WP4595,0.7045415652690991,0.8337743681872254,0.29199441200490445,"['SLC25A15', 'GOT1', 'PYCR1']",0.9999787993408132,0,0,3
338,RAC1/PAK1/p38/MMP2 Pathway WP3303,0.7046930520434828,0.8675284760159753,0.3036288576008416,"['YAP1', 'MAPK11', 'CASP7', 'ANGPT2', 'ANGPT1', 'FN1', 'BAX', 'HRAS', 'ANGPTL1']",0.9999787993408132,0,0,9
339,Type 2 papillary renal cell carcinoma WP4241,0.7068327335822548,0.8435858854074467,0.2926915940834774,"['CDKN1A', 'TGFB1', 'EPAS1', 'ELOB', 'VEGFA']",0.9999787993408132,0,0,5
340,Glioblastoma signaling pathways WP2261,0.7136674336603239,0.8718373589956026,0.29410404915887967,"['PDGFRB', 'CDKN1A', 'CDKN1B', 'PRKCH', 'CDKN2C', 'CCND1', 'CDKN2A', 'PRKCD', 'GAB1', 'PLCG2', 'SPRY2', 'HRAS']",0.9999787993408132,0,0,12
341,Overview of leukocyte-intrinsic Hippo pathway functions WP4542,0.7187396892959992,0.821599109611173,0.27133806208203765,"['YAP1', 'FYB1', 'RAB13', 'FERMT3']",0.9999787993408132,0,0,4
342,Regucalcin in proximal tubule epithelial kidney cells WP4838,0.7187396892959992,0.821599109611173,0.27133806208203765,"['ACTA2', 'CASP8', 'TGFB1', 'BAX']",0.9999787993408132,0,0,4
343,IL-3 signaling pathway WP286,0.7223690264715682,0.8335683033543996,0.2710923781417886,"['HCK', 'JUN', 'TGFB1', 'PTPN6', 'FOS', 'HRAS']",0.9999787993408132,0,0,6
344,Focal Adhesion WP306,0.7263381518173553,0.8957664233576642,0.28641199677201534,"['SHC4', 'SHC3', 'ITGB4', 'TESK2', 'THBS4', 'ACTG1', 'PPP1CC', 'RELN', 'CCND1', 'PDGFD', 'FLNC', 'HRAS', 'PDGFRB', 'JUN', 'CAV3', 'LAMB3', 'EGF', 'LAMB2', 'STYK1', 'FN1', 'VEGFB', 'VEGFC', 'VEGFA', 'MYL5', 'HCK', 'COL5A3']",0.9999787993408132,0,0,26
345,Deregulation of Rab and Rab Effector Genes in Bladder Cancer WP2291,0.7304156776250762,0.787472497249725,0.24737778007196393,"['SYTL4', 'SYTL3']",0.9999787993408132,0,0,2
346,Riboflavin and CoQ disorders WP5037,0.7304156776250762,0.787472497249725,0.24737778007196393,"['SLC52A2', 'RFK']",0.9999787993408132,0,0,2
347,Serotonin and anxiety WP3947,0.7304156776250762,0.787472497249725,0.24737778007196393,"['CRH', 'FOS']",0.9999787993408132,0,0,2
348,Transcription co-factors SKI and SKIL protein partners WP4533,0.7304156776250762,0.787472497249725,0.24737778007196393,"['SATB2', 'MERTK']",0.9999787993408132,0,0,2
349,DNA Replication WP466,0.7322815187930015,0.8144255010041448,0.253767045823421,"['POLD4', 'POLD1', 'RPA3', 'POLE2', 'GMNN']",0.9999787993408132,0,0,5
350,Factors and pathways affecting insulin-like growth factor (IGF1)-Akt signaling WP3850,0.7322815187930015,0.8144255010041448,0.253767045823421,"['MAP1LC3A', 'MSTN', 'IGFBP5', 'TNFSF9', 'PLD1']",0.9999787993408132,0,0,5
351,Alzheimer's disease WP2059,0.7340963804190939,0.851535824593558,0.26322245428094015,"['ATP5MD', 'CASP7', 'CASP8', 'PPP3R2', 'PSEN2', 'CYCS', 'CALM3', 'FADD', 'APOE', 'GAPDH', 'CDK5R1']",0.9999787993408132,0,0,11
352,Thyroid hormones production and their peripheral downstream signaling effects WP4746,0.7340963804190939,0.851535824593558,0.26322245428094015,"['MC4R', 'SLCO1C1', 'CREB3', 'NOTCH1', 'TG', 'PAX8', 'RPS6', 'DIO1', 'PRDM16', 'HRAS', 'TSHR']",0.9999787993408132,0,0,11
353,Fatty Acid Biosynthesis WP357,0.7365295852114951,0.7873847847021599,0.24078689216363322,"['ACLY', 'ACSL5', 'ACACB']",0.9999787993408132,0,0,3
354,Biomarkers for urea cycle disorders WP4583,0.7391767853892625,0.7875601374570447,0.23801497893527626,['GOT1'],0.9999787993408132,0,0,1
355,Glucuronidation WP698,0.7391767853892625,0.7875601374570447,0.23801497893527626,['PGM5'],0.9999787993408132,0,0,1
356,LDLRAD4 and what we know about it WP4904,0.7391767853892625,0.7875601374570447,0.23801497893527626,['TGFBR2'],0.9999787993408132,0,0,1
357,LTF danger signal response pathway WP4478,0.7391767853892625,0.7875601374570447,0.23801497893527626,['TLR4'],0.9999787993408132,0,0,1
358,Serotonin Transporter Activity WP1455,0.7391767853892625,0.7875601374570447,0.23801497893527626,['IL1R1'],0.9999787993408132,0,0,1
359,Vitamin B12 Disorders WP4271,0.7391767853892625,0.7875601374570447,0.23801497893527626,['CUBN'],0.9999787993408132,0,0,1
360,ATM Signaling Network in Development and Disease  WP3878,0.7449637066071878,0.8096812278630461,0.23838616715800764,"['DCLRE1C', 'KAT5', 'CHEK2', 'HSPB1', 'HMGN1', 'CDK5R1']",0.9999787993408132,0,0,6
361,GABA receptor Signaling WP4159,0.7459301315309772,0.7872969997247454,0.2307751266270483,"['SLC32A1', 'GAD1', 'GABRD', 'AP2M1']",0.9999787993408132,0,0,4
362,Neural Crest Cell Migration during Development WP4564,0.7459301315309772,0.7872969997247454,0.2307751266270483,"['JUN', 'FOS', 'EPHB2', 'EPHB3']",0.9999787993408132,0,0,4
363,Renin-angiotensin-aldosterone system (RAAS) WP4756,0.7459301315309772,0.7872969997247454,0.2307751266270483,"['CREB3', 'STAR', 'CALM3', 'CAMK1G']",0.9999787993408132,0,0,4
364,The influence of laminopathies on Wnt signaling WP4844,0.7459301315309772,0.7872969997247454,0.2307751266270483,"['CEBPB', 'CCND1', 'TCF7', 'RUNX2']",0.9999787993408132,0,0,4
365,Pathogenic Escherichia coli infection WP2272,0.7567935916545017,0.8062997207070045,0.2246872931372181,"['TUBB8', 'TUBA1C', 'TUBB6', 'TUBB2A', 'TLR4', 'ACTG1', 'TUBA8']",0.9999787993408132,0,0,7
366,Canonical and non-canonical TGF-B signaling WP3874,0.7656461111321168,0.7268342218837268,0.1940903304609718,"['TGFB1', 'TGFBR2']",0.9999787993408132,0,0,2
367,MAP3K1 role in promoting and blocking gonadal determination WP4872,0.7656461111321168,0.7268342218837268,0.1940903304609718,"['MAPK11', 'GADD45G']",0.9999787993408132,0,0,2
368,MAPK pathway in congenital thyroid cancer WP4928,0.7656461111321168,0.7268342218837268,0.1940903304609718,"['JUN', 'FOS']",0.9999787993408132,0,0,2
369,1q21.1 copy number variation syndrome WP4905,0.7657084362361652,0.7458783152681538,0.19911506047803446,"['FMO5', 'TJP3', 'TJP2']",0.9999787993408132,0,0,3
370,Estrogen signaling pathway WP712,0.7657084362361652,0.7458783152681538,0.19911506047803446,"['JUN', 'GPER1', 'FOS']",0.9999787993408132,0,0,3
371,Mammary gland development pathway - Pregnancy and lactation (Stage 3 of 4) WP2817,0.7657084362361652,0.7458783152681538,0.19911506047803446,"['CEBPB', 'CCND1', 'PRLR']",0.9999787993408132,0,0,3
372,Eukaryotic Transcription Initiation WP405,0.7662002555913321,0.7871212121212121,0.20961959844300482,"['TAF13', 'POLR2E', 'POLR1E', 'TAF7', 'POLR2I', 'POLR2K']",0.9999787993408132,0,0,6
373,Prion disease pathway WP3995,0.7710629373478276,0.7557390586292321,0.1964810292147025,"['PRNP', 'HSPA5', 'RFX5', 'EBF1']",0.9999787993408132,0,0,4
374,Pathways Regulating Hippo Signaling WP4540,0.7775535216642291,0.8210078887648139,0.20656788293305473,"['PDGFRB', 'PRKCH', 'PRKD3', 'PRKAR1A', 'CDH20', 'PRKCD', 'TCF7', 'CDH22', 'FGFR4', 'FGFR3', 'CDH18', 'CDH19']",0.9999787993408132,0,0,12
375,Notch Signaling WP268,0.7782630037235228,0.7617486775659218,0.1909633555719497,"['KCNJ5', 'NOTCH1', 'NOTCH4', 'PSEN2', 'DLL3']",0.9999787993408132,0,0,5
376,ATR Signaling WP3875,0.7847511116136977,0.6749926362297496,0.16361056515609426,['RAD9A'],0.9999787993408132,0,0,1
377,Canonical NF-KB pathway WP4562,0.7847511116136977,0.6749926362297496,0.16361056515609426,['NFKBIE'],0.9999787993408132,0,0,1
378,Hijack of ubiquitination by SARS-CoV-2 WP4860,0.7847511116136977,0.6749926362297496,0.16361056515609426,['ELOB'],0.9999787993408132,0,0,1
379,Leptin and adiponectin WP3934,0.7847511116136977,0.6749926362297496,0.16361056515609426,['LEPR'],0.9999787993408132,0,0,1
380,Mitochondrial CII Assembly WP4920,0.7847511116136977,0.6749926362297496,0.16361056515609426,['SDHAF1'],0.9999787993408132,0,0,1
381,NLR Proteins WP288,0.7847511116136977,0.6749926362297496,0.16361056515609426,['EPHB2'],0.9999787993408132,0,0,1
382,TFs regulate miRNAs related to cardiac hypertrophy WP1559,0.7847511116136977,0.6749926362297496,0.16361056515609426,['TGFB1'],0.9999787993408132,0,0,1
383,16p11.2 distal deletion syndrome WP4950,0.7921976681186645,0.7085224927775485,0.165046302577599,"['C3', 'PLN', 'CD81']",0.9999787993408132,0,0,3
384,Kit receptor signaling pathway WP304,0.794048481141856,0.7686628147322072,0.17726191606318517,"['TEC', 'RPS6', 'PTPN6', 'FOS', 'JUNB', 'HRAS', 'SH2B2']",0.9999787993408132,0,0,7
385,Novel intracellular components of RIG-I-like receptor (RLR) pathway WP3865,0.794048481141856,0.7686628147322072,0.17726191606318517,"['DDX3Y', 'MAPK11', 'MAVS', 'CASP8', 'TRADD', 'FADD', 'TMEM173']",0.9999787993408132,0,0,7
386,p53 transcriptional gene network WP4963,0.794048481141856,0.7686628147322072,0.17726191606318517,"['BTG2', 'CDKN1A', 'NOTCH1', 'GADD45A', 'BAX', 'SLC7A11', 'RPRM']",0.9999787993408132,0,0,7
387,BDNF-TrkB Signaling WP3676,0.7941977328171924,0.7266086514641428,0.16742721084753692,"['TRPC3', 'HOMER1', 'GAB1', 'HRAS']",0.9999787993408132,0,0,4
388,Kisspeptin/kisspeptin receptor system in the ovary WP4871,0.7941977328171924,0.7266086514641428,0.16742721084753692,"['PRKCH', 'STAR', 'PRKCD', 'HRAS']",0.9999787993408132,0,0,4
389,STING pathway in Kawasaki-like disease and COVID-19 WP4961,0.7967989866925864,0.6748585572842999,0.15329604087755772,"['TMEM173', 'NFKBIE']",0.9999787993408132,0,0,2
390,Transcription factor regulation in adipogenesis WP3599,0.7967989866925864,0.6748585572842999,0.15329604087755772,"['CEBPB', 'PCK2']",0.9999787993408132,0,0,2
391,Urea cycle and metabolism of amino groups WP497,0.7967989866925864,0.6748585572842999,0.15329604087755772,"['PYCR1', 'PYCR3']",0.9999787993408132,0,0,2
392,Mechanoregulation and pathology of YAP/TAZ via Hippo and non-Hippo mechanisms WP4534,0.7988540418281429,0.7378794919454771,0.16571078182025065,"['MAP4K1', 'ACTA2', 'ACTC1', 'ITGB4', 'ACTG1']",0.9999787993408132,0,0,5
393,DNA damage response (only ATM dependent) WP710,0.8007753538967756,0.8073429013894039,0.17937127050100277,"['JUN', 'CDKN1A', 'TGFB1', 'CDKN1B', 'WNT5B', 'CDKN2A', 'TCF7', 'WNT16', 'CCND1', 'BAX', 'HRAS', 'LDLR', 'PCK2']",0.9999787993408132,0,0,13
394,Hippo-Merlin Signaling Dysregulation WP4541,0.8007753538967756,0.8073429013894039,0.17937127050100277,"['PDGFRB', 'ITGB4', 'PPP1CC', 'LIN28B', 'CCND1', 'PRKAR1A', 'CDH20', 'CDH22', 'FGFR4', 'FGFR3', 'HRAS', 'CDH18', 'CDH19']",0.9999787993408132,0,0,13
395,Integrated breast cancer pathway WP1984,0.8020864322588965,0.8350804404916912,0.18416772678983853,"['PLK3', 'JUN', 'GADD45A', 'TRADD', 'DCAKD', 'AHR', 'PHB', 'HMGCR', 'JAKMIP1', 'BACH1', 'RASGRP3', 'FOSL2', 'TGFBR2', 'VEGFA', 'CASP8', 'CCND1', 'CHEK2', 'BAX', 'FADD', 'FAU']",0.9999787993408132,0,0,20
396,MAPK Signaling Pathway WP382,0.8031613109677468,0.8623463420455901,0.18902605931784655,"['RASGRF2', 'HSPB1', 'FGF1', 'RASGRP3', 'RPS6KA5', 'PPP3R2', 'DUSP10', 'NTF3', 'FLNC', 'HRAS', 'MAP4K1', 'DUSP4', 'PDGFRB', 'HSPA8', 'JUN', 'DUSP2', 'TGFB1', 'IL1R1', 'GADD45A', 'DUSP1', 'EGF', 'PRKCD', 'FOS', 'DUSP7', 'TGFBR2', 'NR4A1', 'MAPK11', 'DDIT3', 'FGFR4', 'FGFR3', 'HSPA1B', 'FGF10']",0.9999787993408132,0,0,32
397,IL-4 signaling pathway WP395,0.804671798978124,0.7455632883862549,0.16202640120912032,"['MAPK11', 'CEBPB', 'NFIL3', 'STAT6', 'PTPN6', 'FOS']",0.9999787993408132,0,0,6
398,Nucleotide Excision Repair WP4753,0.804671798978124,0.7455632883862549,0.16202640120912032,"['POLE4', 'POLD4', 'POLD1', 'RPA3', 'POLE2', 'POLE3']",0.9999787993408132,0,0,6
399,T-Cell antigen Receptor (TCR) pathway during Staphylococcus aureus infection WP3863,0.804671798978124,0.7455632883862549,0.16202640120912032,"['JUN', 'CD4', 'IL5', 'PTPN6', 'FOS', 'CARD11']",0.9999787993408132,0,0,6
400,Translation inhibitors in chronically activated PDGFRA cells WP4566,0.804671798978124,0.7455632883862549,0.16202640120912032,"['EIF4A2', 'RPS6KA5', 'PRKCD', 'RPS6', 'PIM1', 'PIM2']",0.9999787993408132,0,0,6
401,DNA IR-double strand breaks and cellular response via ATM WP3959,0.810979950272554,0.7511274380848585,0.1573701722994729,"['YAP1', 'DCLRE1C', 'KAT5', 'CDKN2A', 'CHEK2', 'BAX', 'RAD9A']",0.9999787993408132,0,0,7
402,Neural Crest Cell Migration in Cancer WP4565,0.8154114391156709,0.6996360522372083,0.14276945382343598,"['JUN', 'FOS', 'EPHB2', 'EPHB3']",0.9999787993408132,0,0,4
403,Oxidative Stress WP408,0.8161407338536346,0.6747243676670007,0.13708271807881262,"['NOX3', 'FOS', 'JUNB']",0.9999787993408132,0,0,3
404,AMP-activated protein kinase (AMPK) signaling WP1403,0.8174452119190802,0.7553349875930521,0.1522539290417376,"['GYS2', 'CCNA2', 'CDKN1A', 'CRTC2', 'STRADB', 'LEPR', 'HMGCR', 'ACACB']",0.9999787993408132,0,0,8
405,Interleukin-11 Signaling Pathway WP2332,0.8179064972156481,0.7154569236353623,0.14381203264499917,"['TGFB1', 'RPS6', 'IL6ST', 'HRAS', 'RUNX2']",0.9999787993408132,0,0,5
406,15q11.2 copy number variation syndrome WP4940,0.8223647703583614,0.5905670103092784,0.11549791235038082,['TUBGCP4'],0.9999787993408132,0,0,1
407,Biotin Metabolism (including IEMs) WP5031,0.8223647703583614,0.5905670103092784,0.11549791235038082,['ACACB'],0.9999787993408132,0,0,1
408,Estrogen Receptor Pathway WP2881,0.8223647703583614,0.5905670103092784,0.11549791235038082,['JUN'],0.9999787993408132,0,0,1
409,Purine metabolism WP4792,0.8223647703583614,0.5905670103092784,0.11549791235038082,['PRPS1'],0.9999787993408132,0,0,1
410,Thiamine metabolic pathways WP4297,0.8223647703583614,0.5905670103092784,0.11549791235038082,['BCKDK'],0.9999787993408132,0,0,1
411,Ebstein-Barr virus LMP1 signaling WP262,0.8242233877277998,0.6298129812981298,0.1217514677734021,"['HSP90AA1', 'TRADD']",0.9999787993408132,0,0,2
412,Nicotine Activity on Dopaminergic Neurons WP1602,0.8242233877277998,0.6298129812981298,0.1217514677734021,"['CHRNB2', 'SLC18A2']",0.9999787993408132,0,0,2
413,nsp1 from SARS-CoV-2 inhibits translation initiation in the host cell WP5027,0.8242233877277998,0.6298129812981298,0.1217514677734021,"['EIF3I', 'EIF3CL']",0.9999787993408132,0,0,2
414,Thymic Stromal LymphoPoietin (TSLP) Signaling Pathway WP2203,0.8347938128627985,0.6745900672407691,0.12181107607608914,"['HCK', 'TEC', 'RPS6', 'STAT6']",0.9999787993408132,0,0,4
415,Glycosylation and related congenital defects WP4521,0.8376965031068168,0.6439987993846846,0.11405180884724833,"['DPM3', 'MPI', 'DOLK']",0.9999787993408132,0,0,3
416,Signal transduction through IL1R WP4496,0.8376965031068168,0.6439987993846846,0.11405180884724833,"['JUN', 'TGFB1', 'IL1R1']",0.9999787993408132,0,0,3
417,Sphingolipid pathway WP1422,0.8376965031068168,0.6439987993846846,0.11405180884724833,"['CERS4', 'SPHK1', 'SERINC1']",0.9999787993408132,0,0,3
418,Eicosanoid metabolism via cyclooxygenases (COX) WP4719,0.8482708764817452,0.590398102310231,0.09715311581729266,"['HPGD', 'PTGS2']",0.9999787993408132,0,0,2
419,Purine metabolism and related disorders WP4224,0.8482708764817452,0.590398102310231,0.09715311581729266,"['PRPS1', 'AOX1']",0.9999787993408132,0,0,2
420,Type I interferon induction and signaling during SARS-CoV-2 infection WP4868,0.8482708764817452,0.590398102310231,0.09715311581729266,"['MAVS', 'TLR4']",0.9999787993408132,0,0,2
421,16p11.2 proximal deletion syndrome WP4949,0.8501173040265473,0.7323341845833393,0.11891710909961016,"['CASP8', 'ASPHD1', 'KCTD13', 'GDPD3', 'ALDOA', 'SEZ6L2', 'CCT7', 'CDIPT', 'CCT6B']",0.9999787993408132,0,0,9
422,Regulation of Microtubule Cytoskeleton WP2038,0.8516375512139728,0.6744556558682953,0.10831370158719077,"['SPRED1', 'PARD6A', 'CFL2', 'TESK2', 'EPHB2']",0.9999787993408132,0,0,5
423,TNF related weak inducer of apoptosis (TWEAK) Signaling Pathway WP2036,0.8524435827334718,0.6512713915544293,0.10397433834450963,"['CASP7', 'JUN', 'CASP8', 'FADD']",0.9999787993408132,0,0,4
424,PPAR signaling pathway WP3942,0.8528922008350259,0.6908284620036284,0.10992608665938947,"['CPT2', 'FABP6', 'APOA1', 'ACSL5', 'ANGPTL4', 'PCK2']",0.9999787993408132,0,0,6
425,15q13.3 copy number variation syndrome WP4942,0.8534078107088239,0.5249026345933563,0.08320638765489101,['CHRFAM7A'],0.9999787993408132,0,0,1
426,Cancer immunotherapy by CTLA4 blockade WP4582,0.8534078107088239,0.5249026345933563,0.08320638765489101,['PTPN6'],0.9999787993408132,0,0,1
427,Dopamine metabolism WP2436,0.8534078107088239,0.5249026345933563,0.08320638765489101,['TYR'],0.9999787993408132,0,0,1
428,MFAP5-mediated ovarian cancer cell motility and invasiveness WP3301,0.8534078107088239,0.5249026345933563,0.08320638765489101,['JUN'],0.9999787993408132,0,0,1
429,Non-homologous end joining WP438,0.8534078107088239,0.5249026345933563,0.08320638765489101,['DCLRE1C'],0.9999787993408132,0,0,1
430,TCA cycle in senescence WP5050,0.8534078107088239,0.5249026345933563,0.08320638765489101,['GOT1'],0.9999787993408132,0,0,1
431,Circadian rhythm related genes WP3594,0.8538838165729561,0.8041894000954481,0.1270298707211226,"['CHRNB2', 'EGR1', 'JUN', 'MAGEL2', 'EGR3', 'AHCY', 'HOMER1', 'KCNH7', 'SUV39H1', 'SFTPC', 'BHLHE41', 'AHR', 'HCRTR2', 'PER2', 'PPP1CC', 'HTR7', 'STAR', 'NFIL3', 'ADORA2A', 'CRH', 'ID3', 'RPS27A']",0.9999787993408132,0,0,22
432,Nanoparticle-mediated activation of receptor signaling WP2643,0.8570323972804382,0.6159450196486569,0.09502772536594349,"['MAPK11', 'FN1', 'HRAS']",0.9999787993408132,0,0,3
433,Epithelial to mesenchymal transition in colorectal cancer WP4239,0.8641336037133186,0.770056736387501,0.11244975901287267,"['NOTCH1', 'TGFB1', 'WNT5B', 'NOTCH4', 'EIF5A2', 'FN1', 'WNT8A', 'WNT16', 'TGFBR2', 'DLL3', 'CLDN5', 'MAPK11', 'CLDN20', 'MMP15', 'STRAP', 'HRAS']",0.9999787993408132,0,0,16
434,3q29 copy number variation syndrome WP4906,0.8680923698447185,0.6882923384318589,0.09736387470327908,"['CASP7', 'JUN', 'TGFB1', 'NCBP2', 'DYNLT3', 'SLC51A', 'DYNLL2']",0.9999787993408132,0,0,7
435,IL-5 signaling pathway WP127,0.8684651569435301,0.6295072942471787,0.08877803682795489,"['SPRED1', 'JUN', 'RPS6', 'FOS']",0.9999787993408132,0,0,4
436,FBXL10 enhancement of MAP/ERK signaling in diffuse large B-cell lymphoma WP4553,0.8692839850900712,0.5556202679091439,0.07783429405235925,"['H3F3B', 'H2AFZ']",0.9999787993408132,0,0,2
437,Metabolism of Spingolipids in ER and Golgi apparatus WP4142,0.8692839850900712,0.5556202679091439,0.07783429405235925,"['SPHK1', 'B3GALT1']",0.9999787993408132,0,0,2
438,Serotonin Receptor 2 and ELK-SRF/GATA4 signaling WP732,0.8692839850900712,0.5556202679091439,0.07783429405235925,"['HTR2B', 'HRAS']",0.9999787993408132,0,0,2
439,Amino Acid metabolism WP3925,0.873147082375755,0.7077989242863053,0.09601381455733159,"['ACLY', 'LDHA', 'PKM', 'TDO2', 'GOT1', 'MARS2', 'PYCR1', 'ACSS1', 'HIBCH']",0.9999787993408132,0,0,9
440,IL17 signaling pathway WP2112,0.874318945315731,0.5902290548906315,0.07927369027657824,"['CEBPB', 'TRAF3IP2', 'IL17RE']",0.9999787993408132,0,0,3
441,Endoderm differentiation WP2853,0.8769657187711339,0.7526011101599936,0.09880702535995291,"['DUSP4', 'DUSP5', 'DUSP2', 'NOTCH1', 'TGFB1', 'TCF7', 'SLC2A12', 'PBX3', 'WNT8A', 'DKK1', 'GLI2', 'NME1', 'TRIM5', 'TCEAL2', 'TOX']",0.9999787993408132,0,0,15
442,Ganglio Sphingolipid Metabolism WP1423,0.8790276416568285,0.47237113402061853,0.06090703098448857,['B3GALT1'],0.9999787993408132,0,0,1
443,Leptin Insulin Overlap WP3935,0.8790276416568285,0.47237113402061853,0.06090703098448857,['LEPR'],0.9999787993408132,0,0,1
444,"NAD metabolism, sirtuins and aging WP3630",0.8790276416568285,0.47237113402061853,0.06090703098448857,['ROS1'],0.9999787993408132,0,0,1
445,ncRNAs involved in STAT3 signaling in hepatocellular carcinoma WP4337,0.8790276416568285,0.47237113402061853,0.06090703098448857,['IL6ST'],0.9999787993408132,0,0,1
446,Netrin-UNC5B signaling pathway WP4747,0.8829658650716133,0.6091473322500732,0.07581979910941969,"['YAP1', 'JUN', 'ITGB4', 'PTK2B']",0.9999787993408132,0,0,4
447,Effect of progerin on genes involved in Hutchinson-Gilford progeria syndrome WP4320,0.8875886483414189,0.5247066373303997,0.06256962792974792,"['H3F3B', 'SUV39H1']",0.9999787993408132,0,0,2
448,NAD Metabolism in Oncogene-Induced Senescence and Mitochondrial Dysfunction-Associated Senescence WP5046,0.8875886483414189,0.5247066373303997,0.06256962792974792,"['GOT1', 'SCO2']",0.9999787993408132,0,0,2
449,Trans-sulfuration and one-carbon metabolism WP2525,0.8875886483414189,0.5247066373303997,0.06256962792974792,"['AHCY', 'MAT2B']",0.9999787993408132,0,0,2
450,Host-pathogen interaction of human coronaviruses - interferon induction WP4880,0.8897255625600657,0.5665703673132481,0.06619933977602911,"['JUN', 'MAVS', 'FOS']",0.9999787993408132,0,0,3
451,Glycogen Synthesis and Degradation WP500,0.8960536883949005,0.590059867877787,0.06476198994985831,"['GYS2', 'PHKG1', 'CALM3', 'GYG1']",0.9999787993408132,0,0,4
452,Cell Differentiation - Index expanded WP2023,0.9001713716446956,0.4293908153701968,0.04515908394243921,['RUNX2'],0.9999787993408132,0,0,1
453,Regulation of Wnt/B-catenin Signaling by Small Molecule Compounds WP3664,0.9001713716446956,0.4293908153701968,0.04515908394243921,['SFRP4'],0.9999787993408132,0,0,1
454,Translation Factors WP107,0.901540970250983,0.6292011019283746,0.06521656246956528,"['EIF4A2', 'EEF1B2', 'EEF1G', 'EIF3I', 'EIF4H', 'EIF3CL']",0.9999787993408132,0,0,6
455,Retinoblastoma gene in cancer WP2446,0.9022093347733257,0.6739168981618299,0.06935191687331854,"['CCNA2', 'CDKN1A', 'CDKN1B', 'CCND1', 'CCNE2', 'H2AFZ', 'SUV39H1', 'RPA3', 'POLE2']",0.9999787993408132,0,0,9
456,Melatonin metabolism and effects WP3298,0.9034173637148671,0.5447315787802788,0.055328732655554984,"['PER2', 'EDN1', 'APOE']",0.9999787993408132,0,0,3
457,Glycerolipids and Glycerophospholipids WP4722,0.9034895525173784,0.4970470731283655,0.05044567147026999,"['PLD1', 'CDIPT']",0.9999787993408132,0,0,2
458,Toll-like Receptor Signaling related to MyD88 WP3858,0.9034895525173784,0.4970470731283655,0.05044567147026999,"['TICAM2', 'TLR4']",0.9999787993408132,0,0,2
459,TNF-alpha signaling pathway WP231,0.9036446552265903,0.6836068720606584,0.06926241687594296,"['CASP7', 'HSP90AA1', 'JUN', 'CASP8', 'TRADD', 'RFK', 'BAX', 'FADD', 'NFKBIE', 'HRAS']",0.9999787993408132,0,0,10
460,Wnt signaling pathway and pluripotency WP399,0.9115720608156898,0.6737819299905392,0.062381851088499536,"['JUN', 'PRKCH', 'CCND1', 'WNT5B', 'PRKCD', 'TCF7', 'PPM1J', 'PRKD1', 'WNT16', 'LDLR']",0.9999787993408132,0,0,10
461,Insulin Signaling WP481,0.9147613963834319,0.7421079846315969,0.06611589695452035,"['MAP4K1', 'EGR1', 'XBP1', 'JUN', 'PRKCH', 'SHC3', 'RRAD', 'PRKCD', 'GAB1', 'FOS', 'GYS2', 'MAPK11', 'RPS6KA5', 'RHOJ', 'GYG1', 'HRAS', 'SGK2', 'PFKM', 'SH2B2', 'ARF6']",0.9999787993408132,0,0,20
462,MTHFR deficiency WP4288,0.9172676148785436,0.47215346534653463,0.04077329028188202,"['CHDH', 'CYCS']",0.9999787993408132,0,0,2
463,Signal Transduction of S1P Receptor WP26,0.9172676148785436,0.47215346534653463,0.04077329028188202,"['SPHK1', 'S1PR3']",0.9999787993408132,0,0,2
464,Sphingolipid Metabolism (general overview) WP4725,0.9172676148785436,0.47215346534653463,0.04077329028188202,"['CERS4', 'SPHK1']",0.9999787993408132,0,0,2
465,Wnt/beta-catenin signaling pathway in leukemia WP3658,0.9172676148785436,0.47215346534653463,0.04077329028188202,"['CCND1', 'DKK1']",0.9999787993408132,0,0,2
466,Airway smooth muscle cell contraction WP4962,0.9176207628706904,0.39357388316151204,0.03383597417920528,['RYR1'],0.9999787993408132,0,0,1
467,GPR40 Pathway WP3958,0.9176207628706904,0.39357388316151204,0.03383597417920528,['PLCG2'],0.9999787993408132,0,0,1
468,Prolactin Signaling Pathway WP2037,0.9181549635487587,0.6396097068595702,0.054615695300559736,"['JUN', 'TEC', 'RPS6', 'PTPN6', 'FOS', 'HRAS', 'PRLR', 'YWHAG']",0.9999787993408132,0,0,8
469,PDGF Pathway WP2526,0.9184152699479141,0.555253315198912,0.04725518146143274,"['PDGFRB', 'JUN', 'FOS', 'HRAS']",0.9999787993408132,0,0,4
470,Male infertility WP4673,0.9264735302203385,0.6649519562563041,0.050782250112350595,"['ABCB1', 'MSH4', 'MSH5', 'DND1', 'HLA-DRA', 'PEX10', 'AHR', 'HORMAD1', 'TEX15', 'ETV5', 'RAG1']",0.9999787993408132,0,0,11
471,Fibrin Complement Receptor 3 Signaling Pathway WP4136,0.9291789897193022,0.44963067735344964,0.03302712208637406,"['TICAM2', 'TLR4']",0.9999787993408132,0,0,2
472,Sphingolipid Metabolism (integrated pathway) WP4726,0.9291789897193022,0.44963067735344964,0.03302712208637406,"['CERS4', 'SPHK1']",0.9999787993408132,0,0,2
473,NAD+ metabolism WP3644,0.9320210873247952,0.36326724821570183,0.025573955667584435,['NMNAT1'],0.9999787993408132,0,0,1
474,Leptin signaling pathway WP2034,0.9325241508307247,0.6185304207514678,0.04321067670440137,"['CCND1', 'CFL2', 'RPS6', 'LEPR', 'PLCG2', 'BAX', 'HRAS', 'ACACB']",0.9999787993408132,0,0,8
475,Toll-like Receptor Signaling Pathway WP75,0.9336421208059688,0.6003231989176594,0.041219441000534505,"['MAPK11', 'JUN', 'TICAM2', 'CASP8', 'FADD', 'FOS', 'TLR4']",0.9999787993408132,0,0,7
476,AGE/RAGE pathway WP2324,0.9356639074765354,0.5776353516613257,0.038412138704988406,"['LGALS3', 'MSR1', 'JUN', 'CASP8', 'PRKCD', 'CYCS']",0.9999787993408132,0,0,6
477,Fatty acid beta-oxidation WP143,0.9357465146761779,0.4882519532639788,0.032425132917683716,"['TPI1', 'CPT2', 'ACSL5']",0.9999787993408132,0,0,3
478,Rett syndrome causing genes WP4312,0.9389269413007212,0.54859129900195,0.03457091120910338,"['CECR2', 'SATB2', 'IMPDH2', 'TBL1X', 'GABRD']",0.9999787993408132,0,0,5
479,MET in type 1 papillary renal cell carcinoma WP4205,0.9423542268445293,0.5660330578512397,0.03360766834272884,"['CDKN1A', 'JUN', 'RPL11', 'GAB1', 'ETS1', 'HRAS']",0.9999787993408132,0,0,6
480,MFAP5 effect on permeability and motility of endothelial cells via cytoskeleton rearrangement WP4560,0.9439049490801691,0.3372901325478645,0.019471694403362164,['JUN'],0.9999787993408132,0,0,1
481,SARS coronavirus and innate immunity WP4912,0.9439049490801691,0.3372901325478645,0.019471694403362164,['MAVS'],0.9999787993408132,0,0,1
482,TCA Cycle and Deficiency of Pyruvate Dehydrogenase complex (PDHc) WP2453,0.9439049490801691,0.3372901325478645,0.019471694403362164,['ACLY'],0.9999787993408132,0,0,1
483,Target Of Rapamycin (TOR) Signaling WP1471,0.9440767693256025,0.4719356170037144,0.027158853057468915,"['IDI1', 'RRAGA', 'HMGCR']",0.9999787993408132,0,0,3
484,Brain-derived neurotrophic factor (BDNF) signaling pathway WP2380,0.9475891260530698,0.6844560817163556,0.03684720172889118,"['SHC4', 'EGR1', 'LINGO1', 'JUN', 'RAB3A', 'SHC3', 'RPS6', 'PRKCD', 'FOS', 'ACACB', 'BMP2', 'RPS6KA5', 'NTF3', 'PTK2B', 'HRAS', 'SH2B2', 'CDK5R1']",0.9999787993408132,0,0,17
485,Wnt signaling in kidney disease WP4150,0.9483036776660173,0.4104606112785192,0.021787451576125463,"['WNT5B', 'WNT16']",0.9999787993408132,0,0,2
486,ErbB signaling pathway WP673,0.9484103498570459,0.6202618508191007,0.03285403708558648,"['SHC4', 'CDKN1A', 'JUN', 'CDKN1B', 'SHC3', 'CCND1', 'EGF', 'GAB1', 'PLCG2', 'HRAS']",0.9999787993408132,0,0,10
487,Vitamin D-sensitive calcium signaling in depression WP4698,0.9513939842265059,0.4566719475989509,0.022754601389131483,"['CALB1', 'GPX4', 'PVALB']",0.9999787993408132,0,0,3
488,Regulation of toll-like receptor signaling pathway WP1449,0.9530189270005545,0.6121527479143373,0.02945710553963549,"['MAPK11', 'JUN', 'TICAM2', 'CASP8', 'PELI3', 'PELI2', 'PTPN6', 'FADD', 'FOS', 'TLR4']",0.9999787993408132,0,0,10
489,Globo Sphingolipid Metabolism WP1424,0.9537119498283564,0.3147766323024055,0.014918395443009708,['FUT2'],0.9999787993408132,0,0,1
490,Mitochondrial LC-Fatty Acid Beta-Oxidation WP368,0.9537119498283564,0.3147766323024055,0.014918395443009708,['CPT2'],0.9999787993408132,0,0,1
491,Glycerophospholipid Biosynthetic Pathway WP2533,0.9559095717626843,0.3933237073707371,0.017735737120160758,"['GPD1', 'CDIPT']",0.9999787993408132,0,0,2
492,Lipid Metabolism Pathway WP3965,0.9559095717626843,0.3933237073707371,0.017735737120160758,"['ACLY', 'PRKAR1A']",0.9999787993408132,0,0,2
493,MECP2 and Associated Rett Syndrome WP3584,0.9564605150915029,0.559427134058758,0.02490333050934869,"['GABRR2', 'DLX5', 'SST', 'GAD1', 'RPS6', 'OPRK1', 'FKBP5']",0.9999787993408132,0,0,7
494,Envelope proteins and their potential roles in EDMD physiopathology WP4535,0.9566325371335206,0.48385525842173244,0.021452175288319345,"['ADCY10', 'TGFB1', 'BANF1', 'HRAS']",0.9999787993408132,0,0,4
495,Pathways affected in adenoid cystic carcinoma WP3651,0.9588467157167649,0.5338531108685483,0.022434672226129253,"['NOTCH1', 'MYCBP', 'CHEK2', 'FGFR4', 'HRAS', 'FOXP2']",0.9999787993408132,0,0,6
496,7q11.23 copy number variation syndrome WP4932,0.9611565416437792,0.5965504233380836,0.023634127958975768,"['CLDN5', 'ATP5F1B', 'EIF4H', 'ATP5MC3', 'UBE2L6', 'GTF2IRD1', 'ACACB', 'GAPDH', 'ATP5F1E', 'ATP5MC1']",0.9999787993408132,0,0,10
497,Inhibition of exosome biogenesis and secretion by Manumycin A in CRPC cells WP4301,0.9618049234622604,0.29507731958762884,0.011491382292773175,['HRAS'],0.9999787993408132,0,0,1
498,RANKL/RANK signaling pathway WP2018,0.9619358768246355,0.4717175887696119,0.01830617402662185,"['JUN', 'CALCR', 'FOS', 'PAPSS2']",0.9999787993408132,0,0,4
499,Intraflagellar transport proteins binding to dynein WP4532,0.9624367769170121,0.37755775577557754,0.014455516529532704,"['DYNLT3', 'DYNLL2']",0.9999787993408132,0,0,2
500,PI3K-AKT-mTOR signaling pathway and therapeutic opportunities WP3844,0.9624367769170121,0.37755775577557754,0.014455516529532704,"['CDKN1B', 'HRAS']",0.9999787993408132,0,0,2
501,NO/cGMP/PKG mediated Neuroprotection WP4008,0.9634231733866311,0.42891982140847185,0.015982638279548867,"['PDE3A', 'CNGB3', 'CYCS']",0.9999787993408132,0,0,3
502,Structural Pathway of Interleukin 1 (IL-1) WP2637,0.9666317721349659,0.46017200056393626,0.015617156349532056,"['MAPK11', 'RPS6KA5', 'IL1R1', 'FOS']",0.9999787993408132,0,0,4
503,Hippo-Yap signaling pathway WP4537,0.9684833371995348,0.27769557307459064,0.008892923319051034,['MAP4K1'],0.9999787993408132,0,0,1
504,Host-pathogen interaction of human coronaviruses - autophagy WP4863,0.9684833371995348,0.27769557307459064,0.008892923319051034,['MAP1LC3A'],0.9999787993408132,0,0,1
505,miRNAs involvement in the immune response in sepsis WP4329,0.9684833371995348,0.27769557307459064,0.008892923319051034,['TLR4'],0.9999787993408132,0,0,1
506,TCA Cycle (aka Krebs or citric acid cycle) WP78,0.9684833371995348,0.27769557307459064,0.008892923319051034,['IDH3B'],0.9999787993408132,0,0,1
507,Vitamin D in inflammatory diseases WP4482,0.9684833371995348,0.27769557307459064,0.008892923319051034,['DUSP1'],0.9999787993408132,0,0,1
508,CAMKK2  Pathway WP4874,0.9728159746877901,0.34952939738418287,0.00963315132362585,"['FIS1', 'MAP1LC3A']",0.9999787993408132,0,0,2
509,Initiation of transcription and translation elongation at the HIV-1 LTR WP3414,0.9728159746877901,0.34952939738418287,0.00963315132362585,"['PPP3R2', 'SUPT4H1']",0.9999787993408132,0,0,2
510,Nuclear receptors WP170,0.9728159746877901,0.34952939738418287,0.00963315132362585,"['NR4A1', 'NR2F2']",0.9999787993408132,0,0,2
511,Thermogenesis WP4321,0.973756335921738,0.5676015319556371,0.015094894525089416,"['ADCY10', 'CREB3', 'MAPK11', 'CPT2', 'RPS6', 'PRDM16', 'DPF3', 'ACSL5', 'HRAS', 'ACTG1']",0.9999787993408132,0,0,10
512,Follicle Stimulating Hormone (FSH) signaling pathway WP2035,0.9739943546581976,0.2622451317296678,0.006910099270583619,['RPS6'],0.9999787993408132,0,0,1
513,Immune response to tuberculosis WP4197,0.9739943546581976,0.2622451317296678,0.006910099270583619,['IFIT3'],0.9999787993408132,0,0,1
514,T-Cell Receptor and Co-stimulatory Signaling WP2583,0.9785419678447388,0.24842105263157896,0.005388650872005146,['PTPN6'],0.9999787993408132,0,0,1
515,DNA IR-damage and cellular response via ATR WP4016,0.9800563323851073,0.4997870394728601,0.010068323333814732,"['SEM1', 'FEN1', 'BRIP1', 'POLN', 'ABRAXAS1', 'CHEK2', 'RAD9A']",0.9999787993408132,0,0,7
516,MAPK Cascade WP422,0.9803974214994958,0.32536701946056673,0.006441374627586114,"['JUN', 'HRAS']",0.9999787993408132,0,0,2
517,Regulation of Actin Cytoskeleton WP51,0.9804391811290075,0.5937131161011758,0.01172860293980845,"['PDGFRB', 'GSN', 'EGF', 'CHRM5', 'FN1', 'FGF1', 'ACTG1', 'DIAPH3', 'CFL2', 'TMSB4X', 'FGFR4', 'FGFR3', 'WASF2', 'FGF10']",0.9999787993408132,0,0,14
518,Cardiac Hypertrophic Response WP2795,0.9805177138719376,0.41912102027708964,0.008246024739913139,"['MAP4K1', 'TGFB1', 'EGF', 'PRKD1']",0.9999787993408132,0,0,4
519,Arrhythmogenic Right Ventricular Cardiomyopathy WP2118,0.9821773389323828,0.4446938346075612,0.007997105943662165,"['SGCD', 'ITGB4', 'TCF7', 'SGCG', 'ACTG1']",0.9999787993408132,0,0,5
520,Regulatory circuits of the STAT3 signaling pathway WP4538,0.9821773389323828,0.4446938346075612,0.007997105943662165,"['GHR', 'PDGFRB', 'MAPK11', 'DUSP2', 'IL6ST']",0.9999787993408132,0,0,5
521,PKC-gamma calcium signaling pathway in ataxia WP4760,0.9822945349114313,0.23597938144329897,0.004215554992197516,['TRPC3'],0.9999787993408132,0,0,1
522,TLR4 Signaling and Tolerance WP3851,0.9822945349114313,0.23597938144329897,0.004215554992197516,['TLR4'],0.9999787993408132,0,0,1
523,Histone Modifications WP2369,0.9823868303229875,0.37232009036210006,0.006616175400207998,"['SET', 'H3F3B', 'SUV39H1']",0.9999787993408132,0,0,3
524,Ras signaling WP4223,0.9831826100845648,0.6105539341971424,0.010355243796249265,"['PDGFRB', 'SHC4', 'SHC3', 'RASGRF2', 'GAB1', 'RASAL1', 'PLD1', 'ETS1', 'RASGRP3', 'HTR7', 'GNG4', 'PLCG2', 'CALM3', 'FGFR4', 'FGFR3', 'HRAS', 'ARF6']",0.9999787993408132,0,0,17
525,Neurodegeneration with brain iron accumulation (NBIA) subtypes pathway WP4577,0.9848278268314559,0.3627416743388679,0.005545757292111257,"['MAP1LC3A', 'CP', 'FTL']",0.9999787993408132,0,0,3
526,IL-1 signaling pathway WP195,0.9852069599924597,0.4012158054711246,0.005979539100633022,"['JUN', 'IL1R1', 'PELI2', 'HSPB2']",0.9999787993408132,0,0,4
527,EPO Receptor Signaling WP581,0.9853910031861974,0.22472263132056947,0.003307188813151028,['EPOR'],0.9999787993408132,0,0,1
528,Fluoropyrimidine Activity WP1601,0.9853910031861974,0.22472263132056947,0.003307188813151028,['DPYD'],0.9999787993408132,0,0,1
529,Nanoparticle triggered autophagic cell death WP2509,0.9853910031861974,0.22472263132056947,0.003307188813151028,['MAP1LC3A'],0.9999787993408132,0,0,1
530,Type I collagen synthesis in the context of Osteogenesis imperfecta WP4786,0.9853910031861974,0.22472263132056947,0.003307188813151028,['ADAMTS2'],0.9999787993408132,0,0,1
531,Amyotrophic lateral sclerosis (ALS) WP2447,0.985909383060275,0.30432236772064303,0.004318587652863607,"['BAX', 'NEFH']",0.9999787993408132,0,0,2
532,Disruption of postsynaptic signaling by CNV WP4875,0.985909383060275,0.30432236772064303,0.004318587652863607,"['HOMER1', 'YWHAG']",0.9999787993408132,0,0,2
533,Phosphoinositides metabolism WP4971,0.985909383060275,0.30432236772064303,0.004318587652863607,"['PIP4P1', 'PLCG2']",0.9999787993408132,0,0,2
534,Cell migration and invasion through p75NTR WP4561,0.9879460447881038,0.2144892221180881,0.002601152249635791,['JUN'],0.9999787993408132,0,0,1
535,DNA Repair Pathways Full Network WP4946,0.9885187761752957,0.5430342234401886,0.006270764772645005,"['POLE4', 'POLD4', 'BRIP1', 'FEN1', 'DCLRE1C', 'NEIL2', 'CENPX', 'POLD1', 'RPA3', 'POLE2', 'APEX1', 'POLE3']",0.9999787993408132,0,0,12
536,G13 Signaling Pathway WP524,0.991457751611615,0.2773975927004465,0.0023797779997577406,"['CFL2', 'IQGAP2']",0.9999787993408132,0,0,2
537,Mesodermal commitment pathway WP2857,0.992560163056138,0.4953816660857442,0.003699337180699294,"['YAP1', 'MEIS1', 'CCND1', 'PRKAR1A', 'TRIM5', 'SLC2A12', 'PBX3', 'RPL38', 'TOX', 'DKK1']",0.9999787993408132,0,0,10
538,Wnt Signaling Pathway WP363,0.9928965562321911,0.32138033242036546,0.002291053974009845,"['GCKR', 'CCND1', 'ROR2']",0.9999787993408132,0,0,3
539,Ciliopathies WP4803,0.9931292749729839,0.5667517494973048,0.00390743430723302,"['DNAH11', 'DCDC2', 'AK7', 'CCDC28B', 'GLI3', 'GLI2', 'PKHD1', 'TMEM17', 'EVC', 'MAK', 'ARMC4', 'NME9', 'HYDIN', 'CCDC65', 'CCNQ', 'CCDC151', 'DNAI1']",0.9999787993408132,0,0,17
540,G Protein Signaling Pathways WP35,0.993179431544015,0.43946534380598046,0.0030076721781707207,"['PRKCH', 'PRKD3', 'PRKAR1A', 'GNG4', 'PRKCD', 'PRKD1', 'HRAS']",0.9999787993408132,0,0,7
541,Resistin as a regulator of inflammation WP4481,0.9932291860746786,0.18870103092783505,0.0012820045895207417,['PLCG2'],0.9999787993408132,0,0,1
542,Interferon type I signaling pathways WP585,0.9939112313713014,0.31421103315449167,0.0019190064212559203,"['RPS6KA5', 'RPS6', 'PTPN6']",0.9999787993408132,0,0,3
543,Common Pathways Underlying Drug Addiction WP2636,0.994849714410643,0.25483899741325483,0.00131588512429783,"['PPP1CC', 'ACTG1']",0.9999787993408132,0,0,2
544,Splicing factor NOVA regulated synaptic proteins WP4148,0.9956537436837051,0.24811099531005731,0.0010807041941340721,"['NTNG1', 'EPB41']",0.9999787993408132,0,0,2
545,EGF/EGFR signaling pathway WP437,0.9964256364302501,0.522143877598046,0.0018696754984072878,"['MAP4K1', 'NDUFA13', 'JUN', 'EGF', 'PRKCD', 'GAB1', 'FOS', 'PLD1', 'RPS6KA5', 'PTK2B', 'SPRY2', 'FOSB', 'HRAS', 'AP2M1', 'ARF6']",0.9999787993408132,0,0,15
546,Ectoderm Differentiation WP2858,0.997309249878763,0.45215390983188997,0.001218272957781464,"['MAFB', 'PIM1', 'SPRY2', 'ROR2', 'NR2F2', 'TBL1X', 'ARHGAP15', 'JAKMIP1', 'PTPN13', 'GLI3']",0.9999787993408132,0,0,10
547,mBDNF and proBDNF regulation of GABA neurotransmission WP4829,0.997863481800128,0.15209843698037911,0.0003253087166548929,['GABRD'],0.9999787993408132,0,0,1
548,Energy Metabolism WP1541,0.9981527191883024,0.21916493974978893,0.0004052335932602439,"['PPP3R2', 'UCP3']",0.9999787993408132,0,0,2
549,Ciliary landscape WP4352,0.9982688379647057,0.5443631476780648,0.0009431974642560936,"['YAP1', 'DOCK5', 'EXOC8', 'NDUFA5', 'DYNLT3', 'HTRA2', 'COPS7A', 'MYL6B', 'RAB3IL1', 'IQGAP2', 'COX6C', 'DYNLL2', 'LSM4', 'PSMD8', 'EXOSC4', 'TTC30B', 'CDH23', 'TMED1', 'VIM', 'COPS8', 'GLA']",0.9999787993408132,0,0,21
550,Chemokine signaling pathway WP3929,0.9983520554500926,0.418963038215282,0.0006909973746269334,"['SHC4', 'HCK', 'SHC3', 'GNG4', 'PRKCD', 'PTK2B', 'DOCK2', 'CXCL14', 'HRAS']",0.9999787993408132,0,0,9
551,Synaptic signaling pathways associated with autism spectrum disorder WP4539,0.9984451359875541,0.21416516651665166,0.0003332568618793924,"['HOMER1', 'HRAS']",0.9999787993408132,0,0,2
552,MicroRNAs in cardiomyocyte hypertrophy WP1544,0.9992075583507721,0.28095690005792673,0.00022273021125198458,"['EDN1', 'TGFB1', 'EGF', 'IL6ST']",0.9999787993408132,0,0,4
553,Integrin-mediated Cell Adhesion WP185,0.999442419719434,0.30150181637170487,0.00016815835261225505,"['SHC3', 'CAV3', 'ITGB4', 'HRAS', 'MYPN']",0.9999787993408132,0,0,5
554,mRNA Processing WP411,0.9997803335147137,0.3611597339359027,7.934340424307585e-05,"['SF3B5', 'LSM7', 'SF3A1', 'NCBP2', 'CSTF2T', 'SNRPE', 'SNU13', 'SRSF9', 'LSM2']",0.9999787993408132,0,0,9
555,Joubert Syndrome WP4656,0.9998201363838155,0.21063070943261405,3.7888208535306855e-05,"['TMEM17', 'KAT5', 'PDE6B']",0.9999787993408132,0,0,3
556,Fragile X Syndrome  WP4549,0.999913606820188,0.30430006277463906,2.6290585720083136e-05,"['HOMER1', 'PRKAR1A', 'CDKN2A', 'GAD1', 'GAB1', 'GABRD', 'AP2M1']",0.9999787993408132,0,0,7
557,Genes related to primary cilium development (based on CRISPR) WP4536,0.999959771987277,0.24458298912295195,9.839285507037092e-06,"['TMEM17', 'EVC', 'TTC30B', 'CDK20', 'TULP3']",0.9999787993408132,0,0,5
558,Angiopoietin Like Protein 8 Regulatory Pathway WP3915,0.9999787993408132,0.2559353869271225,5.426056430263197e-06,"['MAP4K1', 'SLCO1C1', 'MAPK11', 'RPS6KA5', 'SHC3', 'HRAS']",0.9999787993408132,0,0,6
